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Abstract 
There is some evidence that psychotic symptoms are exacerbated in the days before and 
during menstruation.  Paranoia is frequently reported in psychosis, and is a common 
experience for non-clinical populations. A review of the literature regarding paranoia 
and the menstrual cycle is presented, finding evidence that paranoid experiences 
increase around menstruation for women diagnosed with schizophrenia, episodic 
psychosis or premenstrual syndrome.  This literature is limited in quality and quantity, 
and predominantly psychiatric.   
 
Some general psychological theories of paranoia have investigated the role of self-
esteem, with inconsistent findings.  The evidence regarding menstruation-related 
fluctuations in self-esteem is also contradictory.  Therefore, the research report aimed to 
extend the literature by investigating whether menstrual cycle phase was associated with 
fluctuations in feelings of persecution and self-esteem in a non-clinical population.  
Further, these variables were considered within the psychological theory that self-
esteem would be lower if perceived persecution was felt to be deserved.   
 
The results showed that in the three days before and after menses onset persecution and 
negative self-esteem was higher compared to mid-cycle, while positive self-esteem was 
lower.  At both phases, increased persecution was related to increased negative self-
esteem and decreased positive self-esteem.  Deservedness intensified the relationship 
that persecution had with negative but not positive self-esteem.   
These findings could inform treatment approaches for women who experience 
menstruation-related difficulties and also those vulnerable to paranoid thinking styles.  
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DOES THE MENSTRUAL CYCLE HAVE AN IMPACT ON PARANOID 
THINKING? A REVIEW OF THE LITERATURE 
 
Abstract 
Background. Possible connections between mental health and the menstrual cycle have 
been investigated for over a hundred years.  Some research suggests that there may be a 
connection between the menstrual cycle and psychotic symptoms.  Paranoia is a 
common psychotic symptom found in both clinical and non-clinical populations.  The 
aim of this paper was to review the literature, specifically investigating links between 
paranoia and the menstrual cycle. 
 
Method. Literature published in English between 1960 and 2010 is reviewed.  Eight 
empirical studies and 24 case reports were identified and critically reviewed.  The 
findings of both sources were considered together. 
 
Findings. Paranoia has not been well researched within the context of the menstrual 
cycle.  The majority of literature was written from a psychiatric perspective and 
predominantly biological theories were presented.  Due to the limited nature of the 
research, the conclusions of this review are tentative.  However, there was an indication 
that paranoid experiences increased in the premenstrual and menstrual phases within 
women diagnosed with schizophrenia, episodic psychosis and premenstrual syndrome. 
 
Implications.  The premenstrual and menstrual phase may represent a time of increased 
vulnerability to paranoid thinking for some women.  More systematic research is needed 
to verify the findings, and to explore perspectives other than biological explanations.  
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Introduction 
 
The menstrual cycle is a normal part of a woman‟s reproductive life.  However, for 
some women, the menstrual cycle has a prominent impact on their psychological well-
being.  As a result its effect on mental health has been studied for over a hundred years 
(Brockington, 2005).  This paper is specifically interested in whether and how paranoid 
experiences are affected by menstrual cycle phase. 
 
The menstrual cycle typically follows a twenty eight day pattern. Conventionally, the 
first day of menstruation is counted as day one, with menses usually lasting four to six 
days. This first part of the cycle is termed the follicular phase and is characterised by 
low levels of progesterone and estradiol (the predominant form of oestrogen in 
humans).  The follicular phase continues until ovulation (around day 14) with oestrogen 
levels rising rapidly in the late follicular phase and peaking the day before ovulation.  
The luteal phase commences after ovulation and is characterised by a steady rise in 
progesterone, peaking at the mid-luteal phase (typically day 21).  Estradiol and 
progesterone levels both decline through the late luteal phase until menstruation 
(Farage, Osborn and MacLean, 2008).  Figure 1 illustrates these phases.  One of the 
complications of the literature related to menstruation is that authors use the same 
terminology to define different time periods.  However, the three days before 
menstruation is frequently termed the premenstrual phase, and the three days before and 
including menses is generally termed the paramenstrual phase.   
 
Much research supports the importance of examining the impact of the reproductive  
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Figure 1. Hormonal fluctuations across the menstrual cycle
1
 
 
cycle on mental well-being.    For example, Saunders and Hawton‟s (2006) meta-review 
demonstrated a positive relationship between non-fatal suicidal behaviour and the low 
oestrogen phases of the menstrual cycle. Targum, Caputo and Ball (1991) found that 
47% of female psychiatric admissions occurred during the four to five days before and 
during menses.   Further, it has been estimated that 95% of women have recurrent and 
noticeable increases in negative emotion related to menstruation (Farage et al., 2008).   
Accordingly, research into this topic has been extensive, ranging from the investigation 
of purely physical symptoms, to mood, cognitive functioning, and mating behaviour 
(Farage et al., 2008; Gangestad, Thornhill and Garver-Apgar, 2005). However, many of 
the findings have been inconsistent and cyclical psychological changes are not a routine 
part of clinical assessments.    
                                                          
1
 Adapted from Wikipedia and Wikimedia Commons image from the user Chris 73, freely available at 
http://commons.wikimedia.org/wiki/Image:MenstrualCycle.png under the creative commons cc-by-sa 2.5 
license 
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Premenstrual syndrome (PMS) is the best researched presentation of menstrual 
difficulty (Stanton, Lobel, Sears and DeLuca, 2002).  PMS is characterised by specific 
physical and affective symptoms which appear in apparent synchronicity with hormone 
fluctuations.  The most common symptoms include irritability, hostility, and depressed 
mood; breast pain, bloating, abdominal pain and headaches (Stanton et al., 2002).   Due 
to the affective components of PMS, feelings of depression and anxiety are well 
researched in relation to the menstrual cycle. 
 
Psychosis is a condition that changes the way a person thinks, feels and behaves and 
which is often characterised by difficulty distinguishing between reality and 
imagination (NHS Choices, 2010).    For over one hundred years there have been 
reports in the literature of a relationship between menstrual cycle phase and psychosis 
(Brockington, 2005).   For example, Brockington (2005) reviewed over two hundred 
years of international literature, identifying 27 statistically reliable cases and 200 
possible cases of a relationship between the menstrual cycle and psychotic episodes. 
Further, Bergemann et al. (2002) have found increased psychiatric hospitalisation 
during the paramenstrual phase in women with schizophrenia.   It has been suggested 
that cyclical changes in psychotic symptoms might represent an extreme form of PMS, 
a theory however that Severino and Yonkers (1993) were unable to find sufficient 
evidence in the literature to support.  Other researchers have investigated the hypothesis 
that oestrogen may have a protective function against schizophrenia (Riecher-Rossler, 
2002).  However, at present the evidence is inconclusive, and the mechanism is likely to 
be complicated and multi-faceted (Kulkarni, 2009). 
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As a common symptom of psychotic illness, paranoia has historically been considered 
primarily within the domain of illnesses such as schizophrenia (Whaley, 1999).  
However, theoretical and empirical advances have emphasised the study of paranoia as 
a concept in its own right.  As such, paranoia has been conceptualised as a dimensional 
symptom present in major depression, bipolar disorder and the non-clinical population, 
occurring on a continuum from normal mistrust to the paranoid delusions found in the 
acutely unwell (Ellet, Lopes and Chadwick, 2003).  There is some debate as to whether 
the difference between psychopathological symptoms and normal experience is 
qualitative or whether it is a matter of intensity, persistence and debilitating impact 
(Costello, 1994).  However, its presence in milder forms may indicate a vulnerability to 
developing more severe symptoms.   
 
Vulnerability-stress models propose that people have varying levels of vulnerability to 
developing mental health problems such as psychosis, and that it is the interaction 
between underlying predispositions and life stressors which leads to symptom 
expression (Zubin and Spring, 1977).   As a result, one of the key components of 
psychological approaches (such as Cognitive Behavioural Therapy)  to managing 
paranoia involves helping individuals recognise times and situations when they may be 
more vulnerable so that they can engage proactively in strategies to manage paranoid 
thoughts before they escalate and become problematic (Smith, Nathan, Juniper, Kingsep 
and Lim, 2003).     
 
It has been suggested that for individuals who are predisposed to certain thinking styles 
or behaviours (such as those found in depression, anxiety, bipolar disorder and eating 
disorders), the paramenstrual phase represents a period of increased sensitivity to these 
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predispositions (Pinkerton, Gucio-Pabia & Taylor, 2010).   Some research also indicates 
that some women find situations more stressful during the premenstrual phase than they 
would at other times (Burrage and Schomer, 1993).  If certain cycle phases do increase 
a vulnerability to maladaptive thinking styles, then it is plausible that this vulnerability 
would extend to paranoia.  If this is true, awareness of the impact of menstrual cycle 
phase might be an important consideration in relapse management for women prone to 
paranoid thinking.  Further, conceptualising premenstrual symptoms in this way can be 
combined with theories, such as the oestrogen hypothesis mentioned above (Riecher-
Rossler et al., 2002), to provide a more bio-psycho-social approach. 
 
Aim  
Therefore, the aim of this paper is to review the current literature to explore what is 
known about the relationship between the menstrual cycle and paranoid experiences. 
 
Method 
 
Inclusion/exclusion criteria 
This paper reviewed literature published in English between 1960 and 2010.  To be 
included, a paper had to specifically mention paranoid or persecutory thoughts or 
experiences within the context of the menstrual cycle.  Papers were excluded where 
menstruation and paranoid experiences were each linked to another phenomenon, but 
not considered in relation to each other.   Papers which included pre-menarche or post-
menopause cases were also excluded.  
 
Search strategy 
 As illustrated in Figure 2., an automated database search was conducted on 23rd January  
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Figure 2.  Search strategy of literature review 
2011.  A manual search was then conducted to ensure the inclusion criteria were met. 
Where this process identified further papers of potential interest, these articles were also 
sought and included.   
Databases Medline, ProQuest, PsycINFO, 
PsycARTICLES,  Web of Knowledge 
Search terms:  Menstrual cycle; menstruation; menses; menstru*; premenstrual; 
PMS; ovulation; ovulatory; Late luteal phase dysphoric disorder. 
Cross-referenced with:-Paranoia; paranoid; persecution; persecutory 
Additional search terms:- Menstrual psychosis; periodic psychosis   
Duplicates removed: 
748:- Titles/abstracts manually inspected 
717: Excluded as 
irrelevant 
43: Obtained 
and inspected 
manually 
Assessed for quality 
Excluded:  
2 Very brief case descriptions 
Included: 
8 Empirical studies 
21 Case studies/reports 
14 identified 
through second 
referencing 
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This procedure identified eight empirical studies and 21 case reports or case studies 
describing 24 cases. 
 
Case study research is often considered to be the poorest level of evidence quality 
(Greenhalgh, 2006).  Case studies have limited generalisability due to their small 
sample size.  They are often criticised for having few quality controls, and for relying 
on clinical description rather than formal, systematic measures.    Due to their 
limitations they are usually excluded from systematic literature reviews.   However, 
some researchers argue that case study research has a number of strengths which make 
them an important component to theory development and the accumulation 
of knowledge (e.g. Eisenhardt, 1989; Jensen and Rogers, 2001; Hartley, 1994). Case 
studies typically draw on both quantitative and qualitative data collection techniques, 
providing rich sources of data regarding particular topics and unusual phenomena.  This 
richness of data forms the basis of theory development, guides empirical research and 
informs practitioner understanding (Keen and Packman, 1995).   Policy-makers and 
practitioners are becoming increasingly aware that quantitative meta-analyses can be 
limited in their ability to consider the clinical complexity of cases or capture rare 
phenomena (Lemmer, Grellier and Steven, 1999).  As a result, some researchers have 
begun to develop ways of synthesising quantitative and qualitative research (Dixon-
Wood, Agarwal, Jones, Young and Sutton, 2005).   
 
Jensen and Rogers (2001) suggest that careful, systematic, meta-analysis can address 
some of the weaknesses of individual studies.  Combining results from different 
researchers reduces bias and makes findings more generalisable while maintaining the 
rich data (Larsson, 1993).     
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It was therefore decided that for this review, case study research would not be excluded, 
but rather it would be evaluated using the methodical “cross-case analysis” approach 
described by Miles and Huberman (1994).  This approach is designed to find patterns 
and differences within and between case-studies, which was appropriate given that the 
aim of this paper is exploratory as opposed to hypothesis testing.  Although both case 
studies and case reports were included, for ease of reading, the term “case study” will be 
used from here on. 
 
Theory development often begins with reports of individual cases, from which 
empirical studies evolve to test hypotheses.  To reflect this process, the following 
sections are organised so that the findings from case studies are presented first, followed 
by the empirical studies. 
 
Case study literature 
 
Analysis of case studies 
 
As cross-case analysis involves combining the data from numerous cases, a general 
critique of all of the case studies is presented first to provide a quality context within 
which to consider the results. 
 
Case study quality.  The quality of the case study literature was assessed using the 
criteria described by Lee, Mishna, and Brennenstuhl (2010) and the qualitative critical 
appraisal tool developed by The Critical Appraisal Skills Programme (Public Health 
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Resource Unit , 2006).  These processes do not provide a score but rather consider 
external, internal and construct validity, as well as the reliability of findings, by 
examining design, data collection and analysis procedures.   
 
The majority of the papers aimed to describe interesting cases, as opposed to test 
specific hypotheses, so were not pre-designed. This was reflected in the lack of 
standardised, systematic assessment.  In fact, as can be seen from the summary of the 
case reports presented in Table 1, formal symptom measures were administered in only 
six of the papers.  None of the papers specifically reported scores from measures of 
paranoid experiences.  Therefore, all of the findings regarding paranoia are based on 
clinical description. 
 
There were four studies designed to explore specific phenomena.  Janowsky, Gorney 
and Mandell (1967) investigated hormonal fluctuations and emotional upset associated 
with the menstrual cycle.  Despite being the oldest study, this was the most standardised 
report.  Janowsky et al (1967) attempted to control confounding factors by limiting 
medication and maintaining their participant in hospital for the duration of the study.  
Results were triangulated using self-report, nurse and psychiatrist ratings.  They were 
the only authors to conduct a statistical analysis, which was presented in the context of 
biochemical information and day of cycle. 
 
Abe & Ohta (1995) conducted a longitudinal case series study of adolescents who had 
affective or psychotic episodes.  Symptoms were assessed using clinical interview at 
repeated hospital admissions.  Endo, Daiguji, Asano, Yamashita and Takahashi (1978) 
conducted physiological tests to explore brain and hormonal functioning which they 
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thought might underlie episodic psychosis associated with the menstrual cycle.  
Psychotic symptoms were described by clinical description.  Hsiao and Liu (2007) 
reported unusual manifestations of premenstrual syndrome (one experienced 
persecutory delusions) using formal measures to assess inclusion/exclusion criteria, and 
treatment outcomes.  However, these were not aimed at measuring paranoia.      
 
The Brief Psychiatric Rating Scale (BPRS, Overall and Gorham, 1962) was used by two 
studies (Levitte,1997; Stein et al., 1993).  However, it was not administered or reported 
in a systematic way.  Glick and Stewart (1980) assessed their participantdaily using the 
Global Assessment Scale (GAS; Luborsky, 1962) and reported results graphically.   
 
The remaining papers were even less rigorous.  Six reached the conclusion that 
symptoms and the menstrual cycle were linked from the coincidence of hospital 
admission and menstruation.  The others relied on clinical observations, although 
several at least referred to standardised criteria from the Diagnostic and Statistical 
Manual of Mental Disorders third or fourth edition (DSV-III or DSM-IV), or the 
International Classification of Diseases (ICD-10).   
 
Combining findings from multiple researchers and settings inevitably introduces a 
number of uncontrolled variables such as nurse interventions or family support.  In 
terms of generalisability, all cases were identified opportunistically through hospital 
admission and therefore represent the extreme end of the spectrum.  However, 
combined, generalisability is improved as the cases covered a range of backgrounds, 
levels of intelligence, educational and employment status and were set in a number of 
countries.   
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Table 1  
Summary of case reports 
ID Author N Age Diagnosis if 
given 
Physical assessment Assessment Timing of paranoid experiences 
 Onset Remit Between 
episodes 
A Altschule and 
Brem (1963) 
 
1 13 Menstrual 
psychosis 
Medical exam : Normal 
 
Hospital admission 
 
At menstruation After Nine 
days 
Complete 
remission 
B Janowsky, 
Gorney and 
Mandell 
(1967) 
1 24 PMS Biochemical analysis: 
atypical progesterone, 
hydroxy-corticosteroid 
Formal, systematic, 
statistical assessment: 
Self-report, Nurse 
report, BPRS,  
MMPI,  
Shipley-Harford 
psychological tests.  
 
At ovulation and 
mid-luteal phase 
 Complete 
remission 
C 
D 
E 
Endo, Daiguji, 
Asano, 
Yamashita and 
Takahashi 
(1978) 
 
 
3 
of 
7 
C)15 
D)13 
E) 
23 
Menstrual 
psychosis 
C) EEG: High voltage, 
slow wave burst 
D) none reported 
E) EEG – atypical spike 
wave complex 
Clinical interview, 
graphical presentation 
C) Menses onset 
D) Premenstrual 
phase  
E) before and 
after 
menstruation 
C) menses 
end    
 D) menses 
onset   
E) Not 
specified 
 
 
Complete 
remission 
14 
 
F Felthous, 
Robinson, 
Conroy (1980) 
 
1 21 Menstrual 
psychosis 
Physical, neurologic, 
serum, EEG and 
echoencephalogram: 
Normal 
Clinical description Menses onset After seven 
days 
Complete 
remission 
G Glick and 
Stewart (1980) 
 
1 18 Schizophrenia  Daily: GAS, graphical 
analysis  
Exacerbation in 
premenstrual 
phase 
 
At menses Reduced 
H Berlin, Bergey 
and Money 
(1982) 
1 15 Menstrual 
psychosis 
hormone levels: elevated 
prolactin levels, low 
FSH and LH, elevated 
androstanedione  
 
Clinical description Premenstrual 
phase (estradiol: 
progesterone 
peak) 
After 
menses end 
Complete 
remission 
I Dennerstein, 
Judd, & 
Davies. (1983) 
 
1 26 Depression  Hospital admission 
 
Just before 
menstruation 
 Complete 
remission 
J Conrad & 
Hamilton 
(1985) 
1 16 Bipolar disorder 
with psychotic 
features 
Blood tests: Symptoms 
worse when lithium 
concentration falls  
 
Clinical description Exacerbation of 
psychotic 
features 
premenstrually.   
 
Two days 
after 
menses 
onset 
Continue 
at reduced 
intensity 
K Gerada and 
Reveley 
(1988) 
1 34 Menstrual 
psychosis 
Hypoglycaemia 
premenstrually 
hormone level, EEG, 
blood tests: normal  
Hospital admission 
 
Four to six days 
prior to menses 
Subside at 
menses 
onset, total 
remit at 
menses end 
 
Complete 
remission 
15 
 
L Labbate, 
Shearer & 
Waldrep 
(1991) 
1 35 Premenstrual 
psychosis 
Brain electrical activity 
mapping : right 
temporal-occipital 
abnormality 
 
Clinical description Ten days prior to 
menses 
Menses 
onset 
Complete 
remission 
M Lovestone 
(1992) 
1 21 Menstrual 
psychosis 
Blink rate increased 
when psychotic. 
Physical exam normal. 
 
Clinical description, 
counting blinks 
one or two days 
prior to menses  
Three to 
five days 
later 
Complete 
remission 
N Schenck, 
Mandell and 
Lewis (1992) 
 
1 26 Depression Physical exam, blood 
chemistry and urinalysis, 
thyroid hormone levels: 
normal 
 
DSM-III-R Premenstrual  
 
Two to 
three days 
after 
menses 
onset. 
Complete 
remission 
O Stein, 
Hanulkoglu, 
Blank and 
Elizur (1993) 
1 35 Menstrual 
psychosis 
Physical, gynaecological, 
EEG and endocrine 
measurements returned 
normal 
BPRS,  
Moos Distress 
Questionnaire,  Mini 
Mental State Exam 
 
 48-72 hours 
prior to menses 
24-48 
hours after 
menses 
Complete 
remission 
P 
Q 
Abe and Ohta 
(1995) 
2 
of 
11 
P)12 
Q)12 
Recurrent 
depressive 
disorder with 
psychotic 
features 
 Hospital admission 
ICD-10 
P) Just after 
menses 
Q)Premenstrual 
phase  
Q) for ten 
to 
seventeen 
days 
Complete 
remission 
R Korhonen, 
Saarijarvi, and 
Aito. (1995) 
1 48 Schizoaffective 
psychosis 
Endocrine tests normal 
twice 
Day 2: low estradiol  
DSM-III-R Two weeks 
before menses 
Menses 
onset 
 Unclear 
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S Levitte (1997) 1 37  Chronic 
Paranoid 
Schizophrenia 
 
 BPRS 
 
Exacerbation 6 
days prior to 
menses 
Two days 
after 
menses 
Reduced 
T Shah et al. 
(2003) 
1 16 Menstrual 
psychosis 
Physical, neurological 
and neuro-cognitive tests 
normal. 
Low progesterone in 
follicular phase 
 
Clinical description Five days prior 
to menses,  
two days 
after 
menses end 
Complete 
remission 
U Hsiao and Liu 
(2007) 
 
1 34 Bipolar disorder  ICD-10 
Neuropsychiatric 
Interview, Prospective 
Impact and Severity 
of Menstrual 
Symptoms, Clinical 
Global Impressions 
Scale 
 
One week prior 
to menses  
After Three 
to four days 
Complete 
remission 
V Andreou, 
Syngelakis, 
and Karavatos 
(2008) 
1 21 Menstrual 
psychosis 
MRI, EEG : Normal 
Polycycstic ovaries, 
elevated testosterone and 
Lutenising: Follicle-
stimulating hormones, 
Mild hyperprolactinemia 
 
 
 
Clinical description Premenstrual 
phase 
At menses Almost 
complete 
remission 
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W Sadurni, 
Rodie, de 
Montagut and 
Autet (2009)  
 
1 30 Menstrual 
psychosis 
 Hospital admission 
 
 Three to five 
days before 
menses  
Two to six 
days later 
Complete 
remission 
X Ellison-
Wright and 
O‟Keane 
(2010) 
1 14 Menstrual 
psychosis 
hormone levels, EEG 
and MRI: Normal 
 
Hospital admission 
 
Three days 
before menses  
seven to ten 
days after 
menses 
onset 
Complete 
remission 
18 
 
 
In summary, this body of literature has numerous scientific limitations.  The most 
significant is the lack of formal, controlled measurement and analysis which limits the 
credibility of observations, introduces subjectivity, and threatens the construct validity 
of “paranoia”.  This review will attempt to report only the more reliable data.  However, 
the findings below are presented tentatively, and cannot be considered to be conclusive.   
 
Cross-case analysis.  Following Miles & Huberman‟s (1994) approach, a summary of 
each case was developed.  The summary identified the units of information in each 
report which were then coded.  Analytic categories of codes were clustered together 
within “variables”.  For example, the variable “timing of onset” of paranoid symptoms 
was developed from the cluster of category codes including “two days before 
menstruation” or “at menses”.  Initially a meta-matrix was produced including 33 
variables with up to 34 categories.  
 
The meta-matrix was refined in response to the quality of the data and the relationships 
of interest.  Some variables were excluded, others were clustered together.   Twelve 
relevant and common variables were identified and used to transform descriptive data 
from each case into a standardised format.  Using these variables, cross-case analysis 
was conducted by clustering cases by variable or category to see whether patterns 
emerged.   
 
Results of Case Studies 
Mental health.  Fourteen of the studies described episodic presentation of paranoid 
experiences, along with various other psychotic symptoms, which remitted between 
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episodes.  All 14 corresponded to the description by Brockington (2005) of “Menstrual 
Psychosis” which has the following characteristics: a) acute onset against a background 
of normality, b) of brief duration with full recovery between episodes, c) psychotic 
features, d) occurring in rhythm with the menstrual cycle.  Although Brockington 
reports that menstrual psychosis has been described in the literature since the eighteenth 
century it is not a disorder generally recognised or included in the DSM-IV.  Janowsky 
et al. (1967) described their patient as having an extreme case of PMS.  The other 
studies used the terms “episodic” or “menstrual” psychosis.   
 
The remaining cases consisted of women who had existing mental health problems, for 
whom paranoia was exacerbated close to menstruation.  Two women had a diagnosis of 
schizophrenia, and one a diagnosis of schizoaffective psychosis.  Four women had a 
diagnosis of depression.  For two, depression onset followed child birth.  The other two 
were adolescents, for whom paranoid thoughts presented with primarily depressive 
symptoms, remitting completely between episodes. However, in the same study there 
were two other adolescents who experienced episodic paranoid thoughts, but for whom 
the timing of paranoia did not coincide with the menstrual cycle, illustrating that 
episodic psychosis in females is not necessarily associated with menstruation.   Two 
women had received a diagnosis of bipolar disorder, (one of whom was two weeks post-
partum at illness onset).    
 
Diagnostic decisions were discussed at length as authors had difficulty in whether and 
how to distinguish the cases from other atypical or episodic psychoses (e.g. Gerada and 
Reveley, 1988) or extreme PMS (Dennerstein, Judd & Davies, 1983).  
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Co-morbid symptoms.  Paranoid experiences coincided with other symptoms in all 
cases.  A large range of symptoms were reported, with delusions, hallucinations and 
sleep disturbances being the most common.   Suicidal thoughts were reported in nine 
cases and the only suicide attempts reported (two) occurred during the menstrual phase.  
Premenstrual paranoia, irritability and “PMS” (which is assumed to mean typical 
affective and physical symptoms) were the most common symptoms to endure once 
psychotic symptoms were controlled with medication.   There was no information about 
whether any of the women had previously displayed paranoid thinking styles.   
 
Timing.  Some studies did not provide exact timing of when paranoid experiences 
occurred.  However, Figure 3 illustrates the approximate timing of paranoid 
experiences, predominantly starting in the days prior to menses and remitting at menses 
onset or menses end.   There is considerable variation in the duration of symptoms, with 
a range of three to fifteen days and a mean duration of 6 days.    For ten women, 
paranoid, or other psychotic experiences did not occur at every cycle.   
 
Figure 3. Timing of paranoid experiences 
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Age.  The sample age range was 12 to 47, which coincides with the usual age range of 
menstruation.  There was a slight bias towards younger participants, and the mean age 
was 23 (see Figure 4).  Only two women were over 35.  This might indicate that the 
hormonal imbalances found in adolescence are a factor in these cases.  
 
Figure 4. Distribution of age of cases 
 
Predisposing factors.  Predisposing factors were generally not well discussed.  Family 
histories of psychiatric illness were reported in three cases.  Five women had mothers 
who suffered with PMS.  Fourteen women had pre-existing psychiatric difficulties, and 
five had previously reported symptoms consistent with PMS.  Five of the women had 
had disrupted childhoods, including adoption (1), behavioural difficulties (3) and 
abusive parents (2).   
 
Explanations proposed.  All of the studies were written from a psychiatric perspective, 
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Waldrep, 1991); Endo et al. (1978) proposed an interaction between monoamine 
metabolism, psychological factors and central nervous system activity and Lovestone 
(1995) proposed an interaction between falls in oestrogen and dopamine receptors. The 
information regarding physical explanations was inconsistent.  Ten cases were 
investigated for brain abnormalities, yet only three displayed any irregularity.  Several 
authors drew on the success of hormonal treatments which successfully stabilised five 
women, and were successful in conjunction with other medications for four more.  
Hormonal theories were also supported by Janowsky et al. (1967) who found evidence 
of a correlation between oestrogen levels and behavioural disturbance.  Further, six 
women had hormonal imbalances, another was diagnosed with poly cystic ovary 
syndrome (PCOS) and three developed symptoms post-partum. However, the pattern of 
hormonal irregularities and timing of symptoms was not consistent and hormonal 
therapy did not result in improvements for five women. 
 
Psychological theories were generally not considered.  The exceptions were Janowsky 
et al. (1967) and Shah et al. (2003) who drew on psychodynamic theory suggesting that 
menstrual psychosis may represent an interaction between etiological factors and “ego 
destruction”.  More modern or bio-psycho-social models were not considered. 
 
Summary 
 In summary, all of these cases reported fluctuations in paranoid experiences in time 
with menstrual cycle phase.  For some women, paranoid experiences presented as part 
of exacerbation of an existing mental health problem.  For others, symptoms presented 
against a background of good mental health.  Although paranoid experiences generally 
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presented in the days before and during menstruation, there was significant variation in 
the timing and duration of symptoms which poses a question for hormonal explanations.  
 
The sample size was very small and the case studies were not scientifically rigorous.   
Therefore, the next step was to compare the results with those of the empirical studies.   
 
Empirical Studies 
 
Nine empirical studies were identified which compared symptoms at different points of 
the menstrual cycle (summarised in Table 2).   However, none of the studies focussed 
on paranoia, rather measures of paranoia have been included as part of more general, 
and different aims.  As a result, and in reference to the discussion of quality assessment 
presented by Juni, Altman and Egger (2001), it was decided that the most appropriate 
quality assessment procedure would be to employ the tool for assessing cohort studies 
developed by the Critical Appraisal Skills Programme (Public Health Resource Unit, 
2004).   The assessments of quality will therefore be incorporated into the discussion of 
the papers below. 
 
In-patients diagnosed with Schizophrenia 
Riecher-Rossler, Hafner, Stumbaum, Maurer, Schmidt (1994), So-Hyun, Sang-Bum and 
Sook-Haeng (2001) and Bergemann, Parzer, Runnebaum, Resch and Mundt (2007)  
were all interested in the theory that oestrogen may act as a protective factor against 
schizophrenia.  They investigated whether women who had been diagnosed with 
schizophrenia experienced exacerbation of psychotic symptoms during the late luteal 
phase of the menstrual cycle, when estradiol levels were low.
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Table 2.   
Summary of Empirical Studies 
Population/focus Author N Controls Measures Administered Results 
In-patients 
diagnosed with 
schizophrenia 
Bergemann, 
Parzer, 
Runnebaum, 
Resch and Mundt 
(2007) 
125  
 
 Positive and Negative 
Syndrome Scale 
BPRS 
Reproductive hormones 
Days 2-4, 10-12 and 20-
22 
Paranoia: Decrease from day 10-
12 to 20-22., and days 1-2 to 10-
12.Improvement in psychotic, 
not depressive symptoms in 
luteal phase. 
Generally low estradiol levels 
  
 So-Hyun, Sang-
Bum and Sook-
Haeng (2001) 
24   BPRS 
Daily Rating Form 
Esotrogen and 
progesterone 
Daily for 1 cycle 
5-7 days pre- and post  
menses. 
BPRS Total score: Higher 
premenstrually, lowest in 
postmenstrual phase. 
Paranoia: not significant 
No significant correlation 
between BPRS and estrogen. 
 
 Riecher-Rossler, 
Hafner, 
Stumbaum, 
Maurer, Schmidt 
(1994) 
32   BPRS, BFS, Nurses 
Observation Scale for 
In-patient Evaluation, 
Paranoia Depression 
Scale, Estradiol, 
progesterone, 
Day of admission, days 
2, 7, 13, 14, 21 and 28 
of cycle. 
26 had hyperprolactinemia 
Estradiol low normal range 
Symptomatology improves as 
estradiol rises, strong effect for 
psychotic symptoms, including 
paranoia. 
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Premenstrual 
Magnification of 
Major Depression 
Miller, Miller, 
Chinouth, Coyle 
and Brown 
(2002) 
3 Within-
subjects 
ABA 
design 
SCL-90 
BDI 
Follicular and luteal 
phase for three months 
when nefazadone was 
administered and three 
months when it was not 
 
 
Statistically significant reduction 
in paranoia during both phases 
when nefazadone was 
administered. 
No difference between phases. 
Non-clinical 
administered oral 
contraceptive 
Paoletti al. (2004) 10 
(OC) 
12 SCL-90 
 
Follicular and luteal 
phase first cycle  
Luteal phase third cycle. 
Paranoid ideation: no significant 
change between visits for 
control group or time 1 and 2 of 
OC group.  Significant at third 
visit for OC group 
 
 
Outpatient women 
with PMS/GAD 
McLeod, Hoehn-
Saric, Foster & 
Hipsley (1993) 
41  
 
21 GAD  
only 
19 non-
clinical 
 (HARS) 
 (HSCL-90) 
GAD/PMS premenstrual 
and follicular 
 
GAD and control at 
study entry. 
Paranoia: GAD/PMS: more 
severe in premenstruum. Higher 
scores than control at both times. 
GAD only higher than controls. 
GAD no different to GAD/PMS 
at premenstruum, higher at 
follicular. 
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Women with PMS Choung, 
Colligan, Coulam 
and Bergstralh 
(1988) 
20 20 MMPI Days 7 and 25 of 
menstrual cycle 
Control group: no significant 
change. 
PMS group: Significant increase 
in paranoia at day 25. Identified 
two subgroups 
 Palmer, Lambert 
and Richards 
(1991) 
214  MMPI Self perceived best and 
worst times of cycle 
Paranoia increases in 
premenstruum  (worst time) 
3 subgroups 
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So-Hyun et al. (2001) did not find a significant relationship between BPRS scores and 
estradiol levels although they did find a significant change in total BPRS scores 
between the premenstrual and postmenstrual phases.  However, the subscale measuring 
paranoia did not show significant change.  Both Riecher-Rossler et al. (1994) and 
Bergemann et al. (2007) found significant relationships between paranoia (and other 
psychotic symptoms) and estradiol levels, in that when estradiol levels were lower, 
symptomology increased.  Riecher-Rossler et al. (1994) found that the relationship was 
stronger for psychotic symptoms than affective symptoms, and that changes were more 
marked when changes in estradiol levels were more severe.    Neither found a 
significant change in depression. Interpreting these findings is complicated slightly 
because Riecher-Rossler et al. (1994) did not explicitly say when the low estradiol 
phase is for their sample.  However, they did discuss estradiol fluctuations in normal 
women, describing the three days before and during menses as the low estradiol phase.  
Bergemann et al. (2007) did provide exact timings.  Symptoms were least at days 20-22 
when estradiol was at its highest, and worst at days 2-4 when estradiol levels were 
lowest.  Interestingly, they did not find a significant change in symptoms between days 
2-4 and 10-12, despite there being a significant increase in estradiol.  
 
Discrepancies between the studies may be explained by differences in the study designs.  
Riecher- Rossler et al. (1994) and So-Hyun et al. (2001) both reported small sample 
sizes of 34 and 24 respectively, which might make them vulnerable to the effects of just 
a few participants.  Both Riecher-Rossler et al. (1994)  and Bergemann et al. (2007) 
reported low levels of estradiol generally in their sample.  Riecher-Rossler et al. (1994) 
also report that only six of their participants had a normal ovulation period.  So-Hyun et 
al. (2001) do not compare the hormonal levels of their sample to a normal population, or 
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describe their recruitment strategy, making it difficult to identify whether the 
differences in results may be explained by different hormonal profiles in the samples. 
 
Bergemann et al. (2007) employed a much larger sample size.  However, the results 
were based on two samples from some participants and up to five by others.  It is not 
clear how this was managed in the analysis.   A strength of Reicher-Rossler et al.‟s 
(1994) study was the use of triangulated measures from psychiatrists, nurses and 
participants.  This included a paranoia self-report scale, which, as the only study to 
employ a paranoia-specific scale, lends some weight to their findings in regards to 
paranoia at least.  So-Hyun et al. (2001) asked participants to complete a daily rating 
form of affective, behavioural and somatic symptoms.  It is possible that this primed 
their participants to these symptoms but not psychotic ones. 
 
All three studies employed strict inclusion and exclusion criteria to control for 
extraneous variables.  However, this may have limited generalisability as participants 
with irregular cycles were excluded despite menstrual abnormalities being a common 
phenomenon in women with schizophrenia (Bergemann et al. 2007). 
 
So-Hyun et al. (2001) suggested that their findings support the hypothesis that in 
women diagnosed with schizophrenia, the affective symptoms of PMS are being 
misinterpreted as exacerbation of psychotic symptoms.  However, when considering the 
strengths and limitations of all three studies, it would seem that the other two studies are 
methodologically stronger.  Riecher-Rossler et al. (1994) particularly support the theory 
that estradiol has a protective function in schizophrenia, and Bergemann et al. (2007) 
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particularly support the theory that symptoms are exacerbated at the paramenstrual 
phase for this population. 
 
Women Diagnosed with Depression 
 
One study looked at paranoia and the menstrual cycle within the context of 
depression.  Miller, Miller, Chinouth, Coyle and Brown (2002) evaluated the 
effectiveness of Nefazadone, an antidepressant, compared to placebo, on premenstrual 
magnification of major depression (PMMD).  Participants were three women who met 
DMS-IV criteria for major depression or dysthmic disorder.  The results showed that 
when receiving Nefazadone there was a significant improvement in depression and 
paranoid ideation at both the luteal and follicular phases.  The mean scores reported 
graphically by the authors did not show an obvious change in paranoia for either 
condition between the luteal and follicular phase.  Reporting of exact scores and use of a 
single case series design would have improved the understanding of the results 
considerably.  As a pilot study the sample size of three is much too small to generalise 
from, especially given the limited description of the recruitment procedure and sample. 
So although changes in paranoid experiences at different cycle phases were not apparent 
in this study the methodological limitations mean that the results cannot be considered 
to be conclusive. 
 
Women with PMS 
 
Three studies compared paranoia scores at different phases of the menstrual cycle in 
women diagnosed with PMS.  Choung, Colligan, Coulam and Bergstralh (1988) used 
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the Minnesota Multiphasic Personality Inventory (MMPI; Dahlstrom, Welsh & 
Dahlstrom, 1972) to compare twenty women with PMS to twenty women without PMS 
at days 7 and 25 of the menstrual cycle.  Palmer, Lambert and Richards (1991) also 
used the MMPI to compare scores at the self-perceived “best” and “worst” times of the 
menstrual cycle in 214 outpatients diagnosed with PMS.  McLeod al. (1993) were 
interested in whether the scores on the Hopkins Symptom Checklist (HCL-90; Lipman, 
Covi and Shapiro, 1979) and the Hamilton Anxiety Rating Scale (HARS; Hamilton, 
1959) would change over the menstrual cycle if a woman had PMS and generalised 
anxiety disorder (GAD). 
 
All three studies found that women with PMS reported increased levels of paranoia 
during the premenstrual phase.  Palmer al. (1991) identified three sub-groups within 
their sample, based on MMPI scores.  Although they did not define these sub-types, 
they reported that paranoia scores were significantly higher during the premenstrual/ 
“worst time” for subtypes one and two. The size of change was reported for each sub-
group, although a standardised effect size would have been useful. Subtype one, the 
largest subgroup, included women who demonstrated severe psychological 
maladjustment during the worst phase, whilst being normally adjusted at the “best 
time”.  Subtype two displayed moderate change from the best to the worst time, and 
subtype three, the smallest sub-set, demonstrated significant change on only two of 15 
subscales.  Choung et al. (1988) also identified two subgroups within their sample of 
women who had PMS.  Similar to Palmer et al.‟s (1991) subtypes one and two, one of 
the subgroups demonstrated exacerbation of symptoms that were also present during the 
follicular phase while the other group demonstrated symptoms only at the luteal phase.     
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Choung et al. (1988) compared their PMS group to a control group and norms from 
1983, finding that women with PMS had significantly more symptomology even at the 
follicular phase.  The authors included details of score change sizes which was useful as 
it was comparable to those reported by Palmer et al. (1991).  McLeod et al. (1993) did 
not investigate whether their PMS sample consisted of any subgroups.  They took 
measurements at the follicular and luteal phase for women who had both PMS and 
GAD, and compared these within-subjects, as well as to scores administered regardless 
of phase from women with just GAD, and non-clinical controls.  It was found that both 
the follicular and luteal paranoia scores of the GAD/PMS group were higher than the 
clinical controls.  The GAD/PMS luteal scores were also more severe than the GAD 
only scores.  However, the GAD group‟s scores were higher than the PMS/GAD 
group‟s follicular scores. The GAD group‟s scores could have been artificially inflated 
by higher premenstrual scores mixed with follicular phase scores, or by the PMS/GAD 
group scoring artificially lower during their follicular phase.  The comparisons would 
have been clearer if all three groups had completed measures at both time points. 
McLeod et al. (1993) ensured that researchers were blind to menstrual phase.  However, 
the other researchers did not.  As the MMPI is administered by a professional, blind-
rating would have been useful in reducing the risk of researcher bias. 
 
 
The three studies were in agreement that paranoid experiences increase during the 
premenstrual phase in women with PMS.  These results were consistent across different 
measures.  Together the studies are able to compensate for each other‟s design flaws.  
For example, Choung et al. (1988) employed a small sample size which was bolstered 
by the findings of Palmer et al. (1991).  Likewise, the allocation of best and worst time 
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described by Palmer et al. (1991) was not clear, and their results would have been much 
less robust without corresponding findings from another study.   
 
Non-clinical populations 
 
Paoletti et al. (2004) were the only authors to look exclusively at changes across the 
cycle in a non-clinical sample.  They investigated whether an oral contraceptive could 
modify psychological symptoms in a non-clinical population.  Twelve women were 
recruited to the control group, and ten to the experimental group.  The SCL-90 was 
administered at the follicular and luteal phases of the first month.  The experimental 
group then took the oral contraceptive for two months and both groups were measured 
at the luteal phase of the third month.   Although no statistical test is reported, the 
authors state that there was no difference in scores between the first luteal and follicular 
measurements.  In the experimental group, paranoid ideation, as well as anxiety and 
phobic anxiety, was significantly lower in the luteal phase after taking the oral 
contraceptive.   Interestingly the profiles of the control and experimental groups before 
treatment are different, with the experimental group generally scoring more highly.   
The authors admit that no attempts at randomisation or blinding were attempted, which 
may have biased results.  
 
On its own the small sample size of Paoletti et al.‟s (2004) study limits the 
generalisability of the findings.   This is especially true as the age range of participants 
was just 24 to 26 years of age, indicating a very specific sample.  Choung et al. (1988) 
also found no variation in experiences of paranoia between phases in their non-clinical 
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control group.  However, their sample was also small (twenty), and recruited from a 
specific population of medical staff, limiting the generalisability of their findings. 
Therefore, even combined, it is difficult to draw conclusive results about changes in 
paranoid experiences over the menstrual cycle in non-clinical populations. 
 
Summary  
These papers indicate that levels of paranoid experience increase in the paramenstrual 
phase in women who have a diagnosis of PMS or schizophrenia, although there is some 
inconsistency within the results for women with schizophrenia.  There was not 
sufficient evidence regarding women who have been diagnosed with depression, or 
recruited from non-clinical populations from which to draw conclusions.  
 
Discussion 
 
Limitations 
 
There are a number of limitations which mean that the findings of this review must be 
interpreted with caution.  First of all, the quality of many of the papers was scientifically 
poor, which severely limits the conclusions that can be drawn.  However, given that so 
many of the papers identified were case studies, excluding them would have meant 
ignoring a large part of the literature on this subject.  Further, these papers do provide 
some context in which to place the larger studies, and consider their findings. 
 
The second limitation of this review is that only papers that explicitly mentioned 
paranoia or delusions of persecution were included.  Given the clinical description of 
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the case reports, it is possible that cases where paranoia might have been present may 
not have been identified due to the wording used.   Empirical studies that used measures 
which include paranoia scales may also have been overlooked if the scale either was not 
significant or was not explicitly referred to, which could potentially bias the results. It is 
also true that the review does not account for or compare the many episodic psychoses 
that are not related to the menstrual cycle.  It is possible that the timing of episodes was 
coincidentally linked to menstrual cycle phase, a hypothesis that has not been tested 
here. 
 
Finally, this review only includes papers that were written in English.  Brockington 
(2005) makes reference to studies of menstrual psychosis written in other languages 
which were not pursued for this review, and therefore the literature search is not 
complete. 
 
Discussion of Findings 
 
Despite these limitations, there was a suggestion that paranoid experiences increase in 
the days before and during menstruation for some women, and that there were two 
distinct patterns of presentation.  One pattern is the exacerbation of pre-existing 
symptoms, while the other was the presentation of paranoia (and other symptoms) at the 
paramenstrual phase, but with complete recovery between menses.  For women with 
schizophrenia, both the case studies and the research reports provided evidence of 
symptom exacerbation at the paramenstrual (or at least low estradiol) phase.  The 
evidence regarding depression and bipolar disorder was much more limited.  However, 
four women who experienced paranoia in concurrence with episodic or exacerbated 
35 
 
depressive symptoms were described.  Two women with bipolar disorder also 
demonstrated a similar pattern of paranoia presentation.  In the PMS literature two large 
studies identified one subgroup who demonstrated exacerbation of existing symptoms in 
the premenstruum.  The other subgroup only demonstrated difficulty at the premenstrual 
phase.  The women classified within the case study literature as having “menstrual 
psychosis” presented in the same, although more severe, way, which raises the question 
of whether they might represent a more extreme version of the same subgroup.  It is 
interesting that the studies looking at non-clinical populations did not detect any 
fluctuations in paranoia levels.  Given that paranoia is thought to exist on a spectrum 
with normal experience, it would not seem unreasonable to expect that both of the 
patterns mentioned might be observable in less extreme forms in non-clinical 
populations.  The studies into non-clinical populations were both quite small and 
methodologically limited and would need further verification. 
 
Theoretical Implications 
 
Within the literature, the hypotheses regarding menstruation-related fluctuations in 
psychotic symptoms predominantly focus on hormonal components such as the 
oestrogen hypothesis discussed by Reicher-Rossler (1994) and Bergemann et al. (2007).  
The evidence supporting these theories was inconsistent.  Compellingly, two empirical 
studies and one case study found a statistically significant relationship between estradiol 
levels and psychotic symptoms.   Riecher-Rossler et al. (1994) and Bergemann et al. 
(2007) also found generally lowered levels of estradiol in their samples.  Several of the 
case studies were adolescents, and three experienced symptom onset post-partum when 
their hormone levels were likely to be disrupted.  However, although the case studies 
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were not well-controlled, many of them did report physical and hormonal testing, but 
the results did not present a unified profile of hormone imbalances.  Further, responses 
to hormonal treatment were inconsistent. So, although low estradiol levels may make 
individuals more vulnerable to psychotic symptoms, the theory doesn‟t explain what 
other factors may be important, or explain why psychotic episodes did not necessarily 
occur every month. 
 
Stress vulnerability models (Zubin & Spring, 1977) propose that individuals have 
varying levels of predisposed vulnerability, and it is the interaction of these 
vulnerabilities with other stressors that cause symptom presentation.  Low estradiol  
levels may well represent an increased vulnerability.  However, it is interesting that both 
McCleod et al. (1993) and Choung et al. (1988) reported that women with PMS had 
generally increased levels of distress.  It may be that these women are already 
predisposed to experiencing distress.   It is not clear whether menstrual cycle phase 
causes a change in sensitivity to stress, or whether it acts as a stressor itself (Sabin & 
Slade, 1999).  Nevertheless, the stress-vulnerability perspective could account for the 
wide variation in symptom presentation as well as explaining why symptoms do not 
necessarily occur at every cycle or for every woman.    
 
Clinical Implications  
 
The literature indicated that women with PMS may have an increased predisposition to 
paranoid thinking styles, and that they are particularly susceptible to increased paranoid 
thinking in the premenstruum.  Most treatment approaches to PMS concentrate on 
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affective or physiological fluctuations, and it may be that these programmes would 
benefit from including attention to paranoid thinking styles.  
 
Increasing awareness of times of susceptibility to symptom increase is a common 
component of approaches developed to help people manage psychotic symptoms 
(Freeman, Freeman & Garety, 2006; Smith et al., 2003).   Both Reicher-Rossler et al 
(1994) and Bergemann et al (2007) comment that their samples predominantly entered 
hospital during menstruation, and several of the case studies relied on psychiatric 
admission to link with menstrual timing.  Therefore, for these women, attention to 
menstrual cycle phase could be of considerable importance.  However, menstrual cycle 
phase is not necessarily a routine consideration for professionals working with people 
experiencing paranoia, possibly because it is a taboo subject.  Another reason may be 
that of timing.  Several authors referred to the variability in timing and the difficulty it 
causes in concluding that episodic symptoms are related to the menstrual cycle, or 
whether the timing is coincidental.  It is likely that such variability would also 
contribute to clinicians missing possible associations.  Educating clinicians about the 
potential timing variability and encouraging them to explore these issues 
idiosyncratically may be useful in identifying if and when the menstrual cycle is 
important.  Susceptible women can then consider reducing stress at certain times in their 
cycle, and professionals can incorporate this issue into risk management plans.   Smith 
et al. (2003) suggest further that by personalising assessments of stressors, people are 
better able to understand experiences such as paranoia, which in turn reduces the 
distress that is caused.   
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Future research   
From the literature identified here, it appears that paranoid experiences have not been 
well researched in relation to the menstrual cycle.  Therefore, further research focussing 
specifically on paranoia would be needed to verify whether levels of paranoia are 
different at different phases of the menstrual cycle. 
 
A bias towards endocrine theories was noted in the literature.  Some theories of PMS 
consider bio-psycho-social factors, but as yet they do not extend to paranoid (and 
possibly psychotic) experiences.   Given that theories of mental health difficulties 
increasingly contain biological, psychological and social components it seems unlikely 
that fluctuations in symptoms such as paranoia will be explained purely by hormonal 
activity.   A useful path for future research would be to combine theories from these 
different dimensions to develop more holistic understandings.   Further, it would be 
useful to understand how feelings of paranoia at the paramenstrual phase might affect 
an individual and why such feelings might arise. 
 
The generalisability of the literature is limited as it was primarily conducted with in-
patients or women diagnosed with PMS.  However, paranoid experiences are common 
in non-clinical populations as well as people who have bipolar disorder and major 
depression.  The research into these populations was sparse.  Paranoia is also thought to 
exist on a continuum with normal experiences.   If paranoia and the menstrual cycle do 
indeed interact at the more extreme end of the spectrum, then investigating whether they 
also interact at the less extreme end could be useful for understanding both.   
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Conclusions 
The research identified in this review is not of a quality or quantity to allow definitive 
conclusions to be drawn.  However, there is certainly a suggestion that a relationship 
between the menstrual cycle and paranoid experiences may exist, and that this is most 
likely to present as an increase in paranoid experiences during the paramenstrual phase.   
The case study literature indicated that the timing and presentation of this increase 
varies considerably between individual women.  This poses a challenge which clinicians 
and researchers in this field need to consider.  
 
It appeared that women who experienced persecution associated with the menstrual 
cycle fell into two groups.  The first group included women who experienced some 
distress throughout the cycle, which was exacerbated at the paramenstrual phase.  The 
other group appeared to only demonstrate paranoid thinking, along with other 
symptoms, close to menstruation.   
 
The predominant treatment approaches involved hormonal or antipsychotic medication, 
which reflected the predominantly medical model that these women had been 
considered within.  Given the side-effects associated with such medication, and the 
contribution that psychology has made to treatment approaches for both persecutory 
delusions (Freeman, Bentall and Garety, 2008) and PMS (Connolly, 2001), it seems 
timely and necessary that further psychological research into this topic should be 
conducted.     
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AN INVESTIGATION INTO THE RELATIONSHIPS BETWEEN PARANOIA, 
SELF-ESTEEM AND THE MENSTRUAL CYCLE IN A NON-CLINICAL 
POPULATION 
 
Abstract 
Background. The literature suggests that paranoia and self-esteem may fluctuate in 
response to menstrual cycle phase.  However, the evidence is limited and inconclusive.  
Therefore, this report aimed to contribute a large non-clinical study exploring self-
esteem and paranoia across the menstrual cycle.  Further, the study aimed to investigate 
whether psychological theory developed within the psychosis literature could be applied 
to menstruation-related fluctuations and help explain the contradictory findings 
regarding the relationships between paranoia, self-esteem and the menstrual cycle.  
Specifically, the focus was whether self-esteem is lower when a person believes that 
perceived persecution is deserved.  
 
Method.  An online questionnaire including measures of anxiety, depression, 
persecution, deservedness and self-esteem was completed by 278 participants.  
Responses were compared at the paramenstrual (three days before and after menses 
onset) and mid-cycle phase. 
 
Results.  At the paramenstrual phase anxiety, depression, persecution, and negative self-
esteem were higher and positive self-esteem was lower than at mid-cycle.  A greater 
proportion of people experienced persecution as deserved at the paramenstrual phase.  
Experiencing persecution as deserved was associated with increased depression and 
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negative self-esteem.  Increased levels of deservedness significantly strengthened the 
correlation between persecution and negative but not positive self-esteem. 
 
Implications. These findings suggest that the paramenstrual phase is a time of 
vulnerability to increased paranoid experiences and lowered self-esteem, and thus 
heightened interpersonal sensitivity.  These results can inform approaches to managing 
psychotic and paramenstrual symptoms.  Furthermore, the study illustrated that a model 
developed for psychosis could make a valuable contribution to understanding this aspect 
of menstruation-related distress.   
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1. Introduction 
 
1.1 The Menstrual Cycle and Mental Health. 
The menstrual cycle is characterised by hormonal fluctuations which accompany the 
processes of ovulation and menses in female human reproduction.  The phases of the 
cycle have been linked to changes in both physical and psychological phenomena, the 
presentation and intensity of which varies considerably from woman to woman (Gonda, 
Telek, Juhasz, Lazary, Vargha and Bagdy, 2008).  Typically, negative effects occur in 
the few days preceding and during menstruation.   Since the 18
th
 century, physicians 
have also recorded links between the menstrual cycle and psychotic experiences such as 
hallucinations, delusions and confused or disturbed thoughts (Brockington, 2005).  This 
literature contains various clinical case reports of relationships between the menstrual 
cycle and periodic psychosis (for a review see Brockington, 2005; Mahe & Dumaine, 
2001) as well as exacerbation of bipolar disorder (Hendrick, Altshuler and Burt, 1996), 
and the presentation of  psychotic symptoms associated with major depression (e.g. 
Schenck, Mandell and Lewis, 1992).  Case report and empirical studies also indicate an 
exacerbation of schizophrenic symptoms in the premenstrual and menstrual phases (e.g. 
Bergemann,Parzer, Runnebaum, Resch, and Mundt, 2007; Hsiao, Hsiao and Liu, 2004; 
Harris, 1997;  Levitte, 1997).    
 
There is much research that explores sub-clinical psychotic experiences and the concept 
that psychosis exists on a continuum with normal experiences (van Os, Linscott, Myin-
Germeys, Delespaul and Krabbendam, 2008).  Persecutory delusions (or paranoia, the 
feeling associated with persecutory delusions) are one of the most common types of 
delusion in psychotic patients and have been observed in people with schizophrenia, 
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bipolar disorder and major depression (Bentall, Corcoran, Howard, Blackwood and 
Kinderman, 2001).  Paranoid thoughts are also relatively common in non-clinical 
populations (Freeman, 2007).  Despite this, the majority of the literature cited at the 
beginning of this paper, focuses on menstrual exacerbation of psychotic symptoms at 
the clinical, and therefore more severe, end of the continuum.   Further, although 
research investigating psychosis has moved increasingly towards symptom-led models 
(Bentall, 1990), very little research exists that directly explores whether paranoid 
experiences vary in response to the menstrual cycle.   The purpose of this study is to 
explore whether there is an impact of menstrual-cycle phase at the non-clinical end of 
the paranoia spectrum, and if so, whether this phenomenon makes sense within a current 
psychological model of paranoia. 
 
Much of the research investigating the menstrual cycle and psychiatric disturbances has 
focused on hormonal explanations.  However, despite extensive research, a definitive 
aetiology has not been established (Clayton, 2008). Research into disorders such as 
premenstrual syndrome (PMS) has produced evidence that social, cultural (Bancroft and 
Backstrom, 1985) and cognitive factors (Reading, 1992) also have an impact on 
menstruation-related distress.  As a result, these disorders are increasingly viewed as 
complicated and multi-factorial, and treatment approaches are developing to reflect this 
(Taylor, 1999; Blake, Salkovskis, Gath, Day & Garrod, 1998). It is generally accepted 
that the presentation of psychotic disorders also results from a combination of 
biological, social and psychological factors (e.g. Bentall et al. 2001).  It seems likely 
then that if psychotic symptoms do vary with the menstrual cycle, then there would be 
some overlap between factors which affect menstruation-related difficulties and factors 
which affect psychotic symptoms.   Therefore, theories relating to menstruation-related 
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fluctuations in psychotic symptoms are likely to benefit from incorporating ideas from 
both the psychosis literature and the menstruation literature.  
 
However, at present, treatments for psychotic illnesses related to or exacerbated by the 
menstrual cycle are predominantly hormonal or pharmaceutical (Brockington, 2005; 
Bergemann et al. 2007) despite the increasing desire for treatment choice among service 
user groups (Sainsbury Centre for Mental Health, 2006).  A potential path away from 
medically dominated models might be found by exploring psychological understandings 
of psychotic phenomena, such as paranoia, within the context of the menstrual cycle.  
Such exploration may also contribute to our understanding of how psychological 
processes may be involved in other menstruation-related difficulties. 
 
1.2 Paranoia and Self-esteem  
General theories of paranoia suggest an association with specific information processing 
biases including reasoning about the mental states of others, a tendency to jump to 
conclusions, and attribution biases (Bentall et al., 2001).  There has also been much 
research into the link between self-esteem and paranoia.  Bentall, Kinderman and Kaney 
(1994) suggest that individuals prone to paranoid thinking have a tendency to 
externalise attributions for negative events, thus reducing negative thoughts about the 
self and protecting self-esteem.  However, this increases beliefs that others have 
malevolent intentions, resulting in the feeling of paranoia.    
 
The research findings regarding the link between self-esteem and paranoia have been 
varied.  Some studies have found an association between paranoia and low self-esteem, 
while others have reported relatively high or normal levels of self-esteem in paranoid 
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individuals (For a discussion, see Bentall et al. 2001). There is also some evidence that 
people who have been diagnosed with schizophrenia may paradoxically score highly on 
scales of both positive and negative self-esteem.  Lecomte, Corbiere and Laisné (2006) 
suggest self-esteem is a complicated concept, neither being a static “trait” or a transient 
“state”.  Therefore, measuring both positive and negative self-esteem can be useful for 
making sense of complicated or potentially contradictory self-esteem scores.    
 
Bentall et al. (2001) draw on the work of Trower and Chadwick (1995) to suggest that 
the inconsistent findings in the literature might indicate that people vulnerable to 
paranoia have low implicit self-esteem (their spontaneous, automatic or unconscious 
self-evaluations).  For these individuals, certain cognitive biases, such as attribution 
styles, act as part of a dysfunctional defence system which fluctuates in its ability to 
protect against negative thoughts about the self.   
 
Trower and Chadwick (1995) suggest that there are two types of paranoia, “poor-me” 
and “bad-me”.  Poor-me paranoia is characterised by a feeling of undeserved 
persecution by a bad or inferior other.  Bad-me paranoia is characterised by a feeling of 
persecution that is felt to be deserved, because the individual holds a belief that the self 
is in fact “bad”, and therefore punishment by others is justified.  The difference between 
these two types of paranoia then is strongly dependent on the extent of “deservedness” 
they experience.  Bentall et al. (2001) propose that because negative events are 
attributed to others in poor-me paranoia, self-esteem is protected.  Meanwhile, bad-me 
paranoia reflects a failure of this defensive process, negative events are attributed to the 
self, negative self-schemas are activated and the persecution is experienced as justified.   
If this theory is correct, it would be expected that when feelings of persecution are 
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accompanied by a feeling of “deservedness”, the relationship between persecution and 
self-esteem would be changed (moderated).  Specifically, levels of self-esteem would 
become lower as the feeling of deservedness becomes stronger.   Bad-me paranoia is 
therefore also more likely to be associated with depression than poor-me paranoia where 
persecution may be felt but self-esteem and affect are protected.  Both types of paranoia 
are likely to be associated with increased anxiety (Freeman, 2007).   
 
Recent research by Melo, Taylor and Bentall (2006) has provided evidence that people 
fluctuate between poor-me and bad-me paranoia, and that daily experiences can impact 
on these fluctuations. This idea has been supported by recent research identifying a high 
level of fluctuation in self-esteem levels in people from non-clinical populations who 
regularly experience paranoid thoughts (Thewissen, Bentall, Lecomte, van Os and 
Myin-Germeys, 2008).  The current study is interested in whether the menstrual cycle 
might be a “daily experience” that might impact on these fluctuations, and that this 
impact might be related to fluctuations in self-esteem.   
 
1.3 Self-esteem and the Menstrual Cycle 
 The literature regarding self-esteem and its fluctuation over the menstrual cycle is 
inconsistent.  Edmonds, Cahoon, Steed, and Gardner (1995) for example, found that 
self-esteem was not related to the menstrual cycle in their sample of 68 college students.  
Bloch, Schmidt and Rubinow (1997) found that self-esteem was lower by at least 30% 
in the premenstrual phase as opposed to the seven days following menses for 30 out of 
65 cycles for the sixteen women with PMS.  Taylor (1999) reports finding lower self 
esteem scores in the premenstrual period than post-menstruation in women with PMS.  
However, it has been found that women with PMS have generally lower self-esteem 
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scores than non-clinical controls (Morse, Dennerstein, Varnarides & Burrows, 1998).  
Thewissen, et al. (2008) found that low self-esteem was related to more instability in 
self-esteem generally, and therefore the self-esteem of women with PMS may fluctuate 
in a different pattern to other populations.  A more recent study by Hill and Durante 
(2009) investigated a non-clinical population, finding that self-esteem was higher at the 
least fertile phase of the cycle (late luteal phase), and low around the five days before 
and two days after ovulation (the most fertile point of the cycle).  To explain their 
findings, Hill and Durante (2009) drew on research that indicates that some women are 
more likely to increase self-grooming and ornamentation around ovulation (Haselton, 
Mortezaie, Pillsworth, Bleske-Recheck and Frederick, 2007). Hill and Durante (2009) 
propose that the drop in self-esteem prompts women to put more effort into their 
appearance, thus making themselves more attractive to the opposite sex at the time 
when they are most likely to conceive.  However, there is a considerable body of 
literature indicating that both anxiety and depression are exacerbated in the few days 
before and during menstruation (Clayton, 2008).  As both anxiety and depression are 
related to self-esteem (e.g. Orth, Robins & Brent, 2008; Leary, Schreindorfer & Haupt, 
1995) it would seem intuitive that this would also be when self-esteem is lowest. 
 
Paranoia and low self-esteem both reflect oversensitivity to interactions with others.  
Increased interpersonal oversensitivity is commonly reported within the PMS literature 
(Pinkerton, Guico-Pabia, & Taylor 2010). It seems to make sense then that both self-
esteem and paranoia might fluctuate in response to menstrual cycle phase.   However, 
the inconsistent findings regarding self-esteem might be explained by Bentall et al.‟s 
(2001) proposal that sometimes self-esteem is protected (as in poor-me paranoia), but 
sometimes it is not (as in bad-me paranoia).   
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1.4 Use of the internet   
As mentioned above, this study focussed on non-clinical populations.  Freeman et al. 
(2007) argue that non-clinical populations provide a larger sample, a greater range of 
paranoia scores, and do not have the complications of the impact that being a “patient 
with psychosis” may have on self-esteem.  Accessing a non-clinical population through 
the internet enables access to an even greater sample.  Internet-based studies have 
limitations, such as selection bias, the impact of technological factors outside the 
researcher‟s control and issues of generalisability (Witmer, Colman, & Katzman, 1999).  
However, there is some evidence indicating that on-line participants are more willing to 
disclose self-relevant information (Buchanan, 2001), and Freeman et al. (2005) suggest 
that  the internet provides a safe forum for participants to disclose paranoid thoughts.  
There is also evidence that more women than men participate in online psychological 
studies (Birnbaum, 2001) and, importantly for studies employing repeated measures 
designs, once a participant has entered an online-study it is likely to be fairly easy for 
them to access the internet again to complete subsequent sets of questionnaires.  The 
internet also provides a fast medium for researchers to monitor responses and send 
reminders if necessary.  
    
1.5 Aims   
 First of all the study aimed to examine the relationship that menstrual cycle phase has 
with self-esteem and paranoia to determine whether levels of self-esteem and paranoia 
fluctuate in relation to the menstrual cycle in a non-clinical sample.  Specifically we 
will compare the paramenstrual phase, (defined as day 1 of the menstrual cycle plus or 
minus three days) with the mid-cycle phase (11 to 17 days before menses, around the 
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point of ovulation).  Secondly, the study aimed to investigate whether these two 
phenomena are linked and, if so, whether this provides support for the hypothesis that 
paranoia acts as a defence for self-esteem. To investigate this proposal, the analysis 
considered the differences between people who feel persecution is deserved and those 
who do not.  Then, the analysis considered whether feeling that the persecution is 
deserved changes the way that feelings of persecution impact on levels of self-esteem.  
As anxiety and depression are closely related to both self-esteem and paranoia, these 
variables were also investigated..    
1.6 Hypotheses 
 
Hypothesis 1: Levels of a) anxiety, b) depression and c) persecution will be higher 
during the paramenstrual phase compared to mid-cycle. 
Hypothesis 2: Levels of positive and negative self-esteem will fluctuate between the 
paramenstrual and mid-cycle phase. 
Hypothesis 3:  
a) Increased levels of persecution will be associated with increased levels of 
anxiety. 
b) Increased levels of deservedness will be associated with increased levels of 
depression. 
Hypothesis 4: Within each phase, when persecution is felt to be deserved, there will be 
lower levels of positive self-esteem, and higher levels of negative-self esteem than when 
persecution is not felt to be deserved. 
Hypothesis 5: Changes in self-esteem during the menstrual cycle will be related to 
changes in persecution and deservedness. 
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2. Method 
 
2.1 Design 
 The study employed a repeated-measures within subjects design.  Measures were 
administered using an online questionnaire supported by SurveyMonkey.com. 
 
2.1.1 Population Participants were recruited from a non-clinical population. 
 
2.1.2 Recruitment Participants were recruited from the community using adverts 
placed on various websites and through women‟s organisations (see Appendix A). 
An email containing the same information was sent out to the staff of Barnsley college, 
and notices advertising the study were placed on the University of Sheffield intranet, the 
Barnsley College intranet, the Sheffield College Facebook page, and the University of 
Hallam vacancy advertising site.  Leaflets advertising the study were distributed to 
University of Sheffield students and the University of Sheffield International Women‟s 
Group.  An email was also sent out to the University of Sheffield staff and student 
volunteers list alongside another study which used some of the same measures (see 
Appendix B).  Potential participants were given the option of taking part in both studies 
or one or the other.  If participants wanted to take part in both studies, they completed 
the other study first, and then followed a link to the present study which contained the 
formal measures employed by both.     
 
While it was important that participants were aware that the research was interested in 
the menstrual cycle, the wording of the adverts was designed to appeal to a wide range 
of women, regardless of the presence or absence of specific menstrual cycle complaints.  
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2.1.3 Inclusion/exclusion criteria Participants were between 18 and 45, this age 
range was chosen to minimise anomalies that may be attributable to hormonal 
imbalances during adolescence and menopause.   Participants were excluded if they 
were not menstruating regularly.  Regular menstruation was defined as having a cycle 
between 24 and 34 days (NHS, 2010).  Participants were asked to report their cycle 
length, and where possible, this was verified using the dates that they reported 
menstruating during the study.  As it is unclear how and whether menstrual hormonal 
fluctuations interact with the psychological processes that the study was interested in it 
was decided not to exclude women using hormonal contraceptives.  Participants were 
asked to provide details of hormonal contraception to be considered in the analysis.   
 
2.2 Measures 
 
Women who were interested in taking part followed a link to the study information 
page.  They were then asked to confirm their age, that they had read the information 
provided and gave their consent to participate.  An option to exit the survey was present 
on every page (see Appendix C for full survey, formal measures, consent and 
information pages).   
 
At the first stage of the study participants were asked to provide information regarding 
their age, ethnicity, the length and variability of their menstrual cycle and whether they 
used hormonal contraception (and if so what type).  At each stage participants were also 
asked to report where they were in their cycle before completing the following 
measures:-   
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2.2.1 Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983).  The 
HADS is a 14-item self-report questionnaire that consists of two subscales of seven 
items designed to measure levels of anxiety and depression in non-psychiatric 
populations. The HADS is quick and easy to administer.  In the general population the 
anxiety scale has internal consistency coefficients of 0.80 to 0.84, the depression scale 
0.76 to 0.82 (Bjelland, Dahl, Haug and Neckelmann, 2002).  Test-retest reliability for 
anxiety is 0.79, 0.63 for depression and 0.78 for the full scale and is acceptable for 
weekly administration.  Cronbach‟s alpha was acceptable for anxiety (Paramenstrual α 
= 0.85, mid-cycle α = 0.83), and for depression (Paramenstrual α = 0.85, Mid-cycle = 
0.82). 
 
2.2.2 The Persecution and Deservedness Scale (PADS) Melo, Corcoran, 
Shyrane and Bentall, 2009).  The PADS is a ten item measure which provides scores for 
both persecution and deservedness of persecution.  It is possible to score highly on the 
persecution subscale, while scoring high or low on the deservedness scale, but 
deservedness can only be scored if an individual reports a certain level of persecution. 
 
The persecutory subscale – participants score from 0 (certainly false) to 4 (certainly 
true).  Items explicitly state or imply that the individual is at risk as a consequence of 
the untrustworthiness or malevolence of others.  The scale has good internal 
consistency, with a Cronbach‟s alpha of 0.84.  Acceptable internal consistency was 
found for this study at both phases (Paramenstrual α=0.90, mid-cycle α = 0.91). 
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The deservedness subscale – items follow each persecution item.  Participants only 
complete these items if they scored greater than 1 on the persecutory item.  Participants 
score 0 (not at all) to 4 (very much).  Due to this it is not possible to calculate internal 
consistency using Cronbach‟s alpha.  However, an interclass correlation of 0.43 is 
reported by the authors. 
 
2.2.3  Self-Esteem Rating Scale - Short Form (SERS-sf) Lecomte, Corbiere and 
Laisne (2006).  The SERS-SF is a shortened version of Nugent and Thomas‟ (1993) 
Self-Esteem Raing Scale.  It consists of 20 items, ten measure positive self-esteem, ten 
measure negative self-esteem. Participants rate answers from 1 (never) to 7 (always).  
Each subscale ranges from 10 to 70; high scores indicate high positive or high negative 
self-esteem. The scale has good internal consistency, the positive scale has a 
consistency alpha coefficient of 0.91, and the negative scale of 0.87.  The test-retest 
reliability of the positive and negative scales demonstrate stability of r=0.90 and r=0.91, 
P<0.001, respectively.  Cronbach‟s alpha was acceptable for both the positive self-
esteem scale (paramenstrual α= 0.96, mid-cycle α=0.96), and for negative self-esteem 
(paramenstrual α=0.93, mid-cycle α=0.93). 
 
2.3 Ethical considerations  
This study gained ethical approval from the University of Sheffield Department of 
Psychology Ethics Sub-Committee (DESC).  It was made clear that participation was 
entirely voluntary and participants were free to withdraw from the research at any time, 
without penalty.  Participants confirmed that they were over 18, and an “opt-in” 
informed consent approach was used, and “opt-out” options were included in all emails.  
Internet provider addresses were not recorded and it was made explicit that email 
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addresses were only used to send out reminder emails and link responses.  All email 
addresses would be destroyed once the study was completed and removed from the data 
before the analysis.  All data were password protected.  A contact email was provided 
for direct queries and it was stated that if participants found any of the questions 
distressing they should contact their General Practitioner.  University of Sheffield 
students were provided with information for the student counselling service.   
 
2.4 Procedure 
2.4.1 Pilot Five women were asked to complete the questionnaire designed 
above, to provide timing information for adverts and for information regarding ease of 
completion.  Following this process, the configuration of the questionnaire was changed 
so that respondents could not move on to the next page without completing all items. 
 
2.4.2 The study Participants in the final study were asked to complete the battery 
of measures once a week, for four consecutive weeks.  One week after completion of 
each phase, participants were contacted by email with the link to the next phase 
(Appendix D).  If they did not complete the study within two days a reminder email was 
sent (Appendix E).   Two weeks after completing the study participants were emailed to 
ask for the date of their next period (Appendix F).  
 
Participants‟ reports of menstruation date were considered to be more accurate than 
mid-cycle estimates of where they were in their cycles.  The menstruation dates were 
therefore used to allocate responses to menstrual cycle phase.  The “paramenstrual 
phase” (day 1 of their period plus or minus three days) and “mid cycle phase” (11 to 17 
days prior to menses) were used for the data analysis. 
64 
 
    
Allocation was done in this way because although the luteal phase duration is fairly 
consistent, the duration of the follicular phase can be highly variable (Leibenluft, Fiero 
& Rubinow, 1994).  Therefore allocation to mid-cycle had to be calculated by counting 
backwards from the first day of the period.  It was anticipated that asking participants to 
estimate these time points would be difficult and unreliable, therefore measures were 
completed on more than two occasions to maximise the chances of capturing the points 
of interest.  Further, very few participants completed each section of the study exactly at 
the time required.  It is likely that many participants would have found it difficult to 
complete the study correctly if there had been additional timing demands.   
 
Where participants had a shorter than four week cycle, or completed the study over 
longer than four weeks, duplicate phase responses occurred.  In these cases the first 
response was used.  
 
A binomial test was conducted, which found that the entry timings of participants were 
naturally well counter-balanced, with 150 (53.96%) participants completing their 
paramenstrual response before their mid-cycle response, and 128 (46.04%) completing 
their mid-cycle response before their paramenstrual response (p=0.21, two-tailed).  
Therefore order effects should have been offset.   
 
2.5 The sample  
2.5.1 Non-completion. Not all of the organisations were able to provide figures 
regarding site visitors or advert hits, however from the available figures, the response 
rates ranged between 1 and 11 % (see Appendix G for a complete list of organisations 
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and figures, where available).  1069 women entered the first week of the study.  725 
(68%) did not complete the study.  Completion rates for each week are displayed in 
Table 1. 
 
Table 1.   
Weekly completion rates. 
 Entered  Week 1  Week 2 Week 3 Week 4 Total  
University  509 471 (93%) 323 (69%) 227 (70%) 192 (85%) 38% 
Community 560 466   (83%) 293 (63%) 172 (59%) 152 (88%) 27% 
Total 1069 937  
(88%) 
616 (57%) 399 (65%) 344 (86%) 32% 
 
 
  2.5.2Participants excluded.  Figure 1 illustrates the decision making process for 
the 66 participants excluded from the study.  33 participants did not provide the follow-
up information of their period date after completing the study and therefore could not be 
reliably allocated to the comparison points. The cycle length of ten participants was 
outside the acceptable criteria during the period of study (five were too long, five were 
too short).  Sixteen participants did not provide responses at the time points required for 
the analysis, eight had prolonged gaps between response completion, and eight 
completed correctly but coincidentally missed the point of interest.  Seven participants 
were excluded due to completion errors indicating that they did not understand the 
instructions, as five indicated that they were at the same point in their cycle at each 
response, and two participant responses did not fit with the timing of response 
completion.   
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Figure 1. Excluded participants 
 
2.5.3 The final sample. The final sample consisted of 278 individuals.  126 
participants were recruited from the community.   152 were recruited through university 
staff and student populations.   Participants in the final sample were compared to those 
who dropped out in order to identify whether there were any important differences (see 
Table 2).  Using a Mann Whitney U test, it was found that women included in the study 
(Mdn=27) were significantly older than those who did not complete the study 
(Mdn=25), U= 89612.00, p=0.01.  A chi-squared test also identified that there was a 
significant difference between the two groups in terms of the ethnic mix, where a higher 
percentage of the final sample than would be expected indicated their ethnic origin as 
„White‟ or „Mixed‟, and a lower percentage indicated that their ethnic origin was 
„Black‟, „Asian‟ or „Other‟, χ² (4, N=1003) = 14.35, p=0.01.    
344 completed all weeks 
33 couldn't be allocated due to 
lack of follow up information 
10: Cycle length outside 
specified criteria 
16: Critical time points missed  
7: excluded due to completion 
errors  
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Table 2  
Comparison of Demographic Information of the Final Sample and People Who Did Not 
Complete the Study. 
 Dropped-out  
N =725 
Included 
N=278 
p 
Age   Mean:27.2  
SD: 8.35 
Range 18-48 
Mean: 28.25 
SD:7.43 
Range:27 (18-45) 
0.01 
Ethnicity  White = 596 (82%) 
Mixed =18  (2.5%) 
Asian = 62 (8.6%) 
Black = 37 (5.1%) 
Other = 12 (1.7%) 
White = 247 
(88.8%) 
Mixed: 10 (3.6 %) 
Asian: 16 (5.8%) 
Black: 2 (0.7%) 
Other: 3 (1.1%) 
0.01 
Hormonal 
contraceptive use 
No= 478 (65.9%) 
Yes= 247 (34.1%) 
No: 189 (68%) 
Yes: 89 (32%) 
 
0.27 
Average cycle 
length 
Mean: 28.4 days, 
SD 3.47,   
Range: 14-45 
Mean: 28.43 days, 
SD: 2.11 
Range: 24-35 
0.47 
 
2.6 Analysis Procedure  
The analyses were organised as follows:- 
1) Exploration of the data. 
2) Comparison of the measures at the paramenstrual and mid-cycle phases. 
3) Comparisons between people who do not experience feelings of persecution, 
people who experience feelings of persecution but do not feel it is deserved, 
and people who experience feelings of persecution which they feel is 
deserved. 
4) Investigation of the relationships between the variables. 
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5) Investigation of whether deservedness changes the relationships between 
persecution and self-esteem. 
6)  Investigation of the relationships between the variables in terms of how 
much participants changed between menstrual cycle phases.  
 
2.6.1 Power analysis. An a priori power analysis was conducted using G*Power 
(Faul, Erdfelder, Lang & Buchner, 2009). For the comparisons between scores at 
different phases, a power analysis for a Wilcoxon Signed-Ranks test was conducted to 
determine a sufficient sample size using an alpha of 0.05, a power of 0.80, a medium 
effect size (d = 0.30), resulting in 74 participants being required.  For a Chi Square test 
with the same parameters and 1 degree of freedom a sample of 134 was required.  For a 
hierarchical regression analysis, assuming a medium effect size of R² = 0.15, a 
significance level of alpha =0.05, two tested predictors, and five total predictors, a 
sample size of 68 is needed to achieve 80% power. 
 
Jaccard, Turrisi and Wan (1990) provide recommendations that for achieving power of 
0.80 using an alpha of 0.05 with one interaction term, where the squared multiple 
correlation for the main effects model would be 0.15, and the full model would be 0.20 
a sample size of 135 is required.  Although previous research did not provide 
information that could be used for estimating effect sizes for this study, research into 
non-clinical populations employed larger sample sizes.  Pickering, Simpson and Bentall 
(2008) recruited 551 participants for their study, Freeman et al. (2005) recruited 1202, 
and Ellett, Lopes and Chadwick (2003) recruited 324.  As it was anticipated that the 
samples might need to be disaggregated depending on factors such as use of hormonal 
contraception it was decided that between 164 and 300 participants would be required. 
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3. Results 
 
The statistical analysis was conducted using PASW Statistics 18. 
3.1 Distribution of scores 
Prior to analysis, a check for normality was conducted on all scales.  Kolmogorov-
Smirnov analyses and visual checks using QQ-plots and histograms demonstrated that 
apart from the scale for positive self-esteem at the paramenstrual phase (z=0.05, 
p=0.20), none of the scales were normally distributed (Z value range 0.07 to 0.20, 
p<0.05).  Data transformation was not successful, and therefore non-parametric 
statistical procedures were employed.   
 
However, hypothesis 4 was particularly interested in how deservedness changed the 
relationship between persecution and positive and negative self-esteem.  A moderation 
regression was the method most suitable for examining this hypothesis. Further, 
hypothesis 5 was specifically interested in the relationships between the variables, for 
which a regression analysis was most useful.  Following the procedures described by 
Tabachnick and Fidell (2001, pp 125-128) and Field (2006, pp 162-175), the residuals 
of the regression analyses, were checked for normality, linearity, and homoscedacity.  
Durbin-Watson statistics, and tolerance statistics were examined in regards to 
autocorrelation and multicollinearity.  None of the assumptions were violated, and 
therefore it was decided that although the original data was not ideal for a regression 
analysis, the regression models were robust enough for this analysis procedure to be 
employed. 
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Outliers existed within the data.  However, a comparison of mean scores and 5% 
trimmed means and tolerance statistics showed that the impact of outliers across 
measures was minimal . The Cook‟s distance of all of the regression analyses was 
below one, indicating that the outliers did not significantly influence the overall models. 
Further, examination of individual cases did not identify any questionable response 
patterns, rather the scores seemed to reflect participants who had high scores on the 
measures, and therefore the outliers were not excluded from the analysis (Kolmogorov-
Smirnov and trimmed mean analyses are available in Appendix H).   
3.2 Comparison of cycle phases 
 
3.2.1 Overall sample. Table 3 illustrates the mean scores and standard deviations 
of the sample across the measures at the paramenstrual phase and at mid-cycle.  It is 
worth noting that the clinical cut-off for “caseness” for the HADS anxiety and 
depression scores is 8.   
 
Table 3  
Mean (and standard deviation) Scores at the Paramenstrual and Mid-Cycle Phases 
 Paramenstrual Mid-cycle 
 Mean (SD) Range Mean (SD) Range 
Anxiety 7.78 (4.37) 0-20 6.1  (3.75) 0-17 
Depression 4.49 (3.80) 0-21 3.05(3.15) 0-16 
Positive Self-esteem 47.54 (11.34) 10-70 49.67 (10.90) 19-70 
Negative Self-esteem 32.22 (9.98) 16-64 30.22 (9.08) 16-68 
Persecution 1.30 (0.96) 0-3.8 1.14  (0.92) 0-3.9 
Deservedness 1.36  (0.93) 0-4 1.19 (0.85) 0-4 
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Wilcoxon-Signed Ranks tests were used to test the hypotheses that levels of anxiety, 
depression and persecution would be significantly higher at the paramenstrual phase 
compared to mid-cycle, and that there would be a significant difference in positive and 
negative self-esteem scores between phases (median scores, Z values and significance 
levels are displayed in Table 4).  
 
Anxiety, depression, persecution and negative self-esteem were all significantly higher 
at the paramenstrual phase than at mid-cycle.  Positive self-esteem was found to be 
significantly higher at mid-cycle than at the paramenstrual phase. 
 
Table 4  
Summary Statistics of Wilcoxon-Signed Ranks Tests for Differences in Measures 
Between Phases 
N=278 Para-
menstrual 
Mdn 
Mid-cycle 
 
Mdn 
Ties Z P  Effect 
size 
Power 
Anxiety 7 6 33 -6.62 P<0.001ᵅ 0.40 0.99 
Depression 3 2 51 -5.74 P<0.001ᵅ 0.34 0.99 
Positive  
Self-esteem 
48 51 28 4.39 P<0.001ᵇ 0.26 0.99 
Negative  
Self-esteem 
31 29 27 4.85 P<0.001ᵇ 0.29 0.99 
Persecution 1.2 1 40 4.18 P<0.001ᵅ 0.25 0.99 
Note ᵅ one-tailed, ᵇ two-tailed 
 
3.2.2 Recruitment population.  A consideration for the analysis was whether 
subgroups existed within the sample, and whether these subgroups impacted upon the 
overall analysis.  Previous research has indicated that results based on University 
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populations may not reflect more diverse populations (Peterson, 2001).  Therefore the 
sample was divided so that participants recruited through University populations 
represented one subgroup, and participants recruited from other sources formed another 
group, referred to as “community”.  Mann Whitney U tests showed that at mid-cycle, 
the University (Mdn=3) scored significantly higher for depression than the community 
sample (Mdn=2), U = 8027, p=0.01 (one-tailed – this level of significance was used as 
it was a more conservative test of differences).  However, the effect size was small, 
r=0.19.  It was therefore decided that the University and Community populations were 
similar enough to be analysed together.  See Table 5 for mean scores of the two groups 
and summary statistics of the Mann Whitney U tests are available in Appendix I.  
Table 5  
Comparison of Mean Scores by Recruitment Group 
Phase  University 
Mean (SD) 
n= 152 
Community 
Mean (SD) 
n=126 
Para-
menstrual 
Anxiety 7.67 (4.25) 7.90 (4.52) 
Depression 4.30 (3.97) 4.72 (3.58) 
 Positive Self-esteem 47.39 (11.38) 47.72 (11.34) 
 Negative Self-esteem 32.25 (10.48) 32.17 (9.39) 
 Persecution 1.31 (1.02) 1.28 (0.89) 
 Deservedness 1.41 (0.83) 1.3 (0.83)  
Mid-cycle Anxiety 5.92 (3.69) 6.31 (3.83)  
Depression 2.68 (2.90) 3.49 (3.38) 
 Positive Self-esteem 50.11 (10.67) 49.13 (11.18) 
 Negative Self-esteem 29.74 (9.13) 30.79 (9.03) 
 Persecution 1.12 (0.93) 1.17 (0.90) 
 Deservedness 1.24 (0.82) 1.13 (0.73) 
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3.2.3 Use of hormonal contraception. As hormone levels are a pertinent 
characteristic of the menstrual cycle, a second potential division was the use of 
hormonal contraceptives. The sample was therefore divided into a subgroup that used 
hormonal contraception, and a subgroup that did not.   
 
Using a one-tailed Mann-Whitney U test, at the paramenstrual phase, people using 
hormonal contraception (Mdn=3) had a significantly lower depression score than those 
who were not (Mdn=4), U=6681.5, p=0.003, r=0.17, and significantly higher 
(Mdn=52) positive self-esteem scores than those who did not (Mdn= 50), U=7324.5, p= 
0.042, r=0.10.   
 
At mid-cycle, people using hormonal contraception (Mdn=1) had significantly lower 
depression scores than the group not using hormonal contraception (Mdn=2), U = 
7299.50, p=0.04, r=0.10.  Table 6 provides a summary of the mean scores and Mann-
Whitney U tests are available in Appendix I.  The effect sizes of the differences were all 
small.  However, to further examine whether these differences were important, the next 
stage of the analysis was conducted for these variables with the sample disaggregated 
into the two groups.  It was found that the two groups showed a similar pattern, 
although the effect sizes for the group using hormonal contraception was slightly 
smaller.  When use of contraception was entered into regression equations as a dummy 
variable, it was not found to be a significant predictor (p>0.05).  It was therefore 
decided to combine the subgroups for analysis.   Details of the analysis of the 
disaggregated groups are available in Appendix I. 
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Table 6 
 Comparison of Mean Scores (and Standard Deviations) by Use of Hormonal 
Contraception 
Phase  Using Hormonal 
Contraception 
Mean (SD) 
n= 89 
Not Using Hormonal 
Contraception 
Mean (SD) 
n=189 
Para-
menstrual 
Anxiety 7.63 (3.96) 7.85 (4.55) 
Depression 3.48 (2.91) 4.96 (4.07) 
 Positive Self-
esteem 
49.20 (10.03) 46.76 (11.86) 
 Negative Self-
esteem 
30.70 (8.94) 32.93 (10.38) 
 Persecution 1.26 (0.94) 1.32 (0.97) 
 Deservedness 1.16 (0.71) 1.47 (0.86)  
Mid-cycle Anxiety 6.35 (3.82) 2.65 (3.04)  
Depression 2.65 (3.04) 3.24 (3.19) 
 Positive Self-
esteem 
50.18 (10.34) 49.42 (11.17) 
 Negative Self-
esteem 
29.03 (8.04) 30.77 (9.51) 
 Persecution 1.13 (0.92) 1.12 (0.76) 
 Deservedness 1.15 (0.92) 1.23 (0.79) 
 
 
3.2.4  Proportion of participants experiencing persecution.  A McNemar‟s test 
was conducted to determine whether there was an effect of cycle phase on the 
proportion of participants who experienced persecution at each cycle phase.  A 
significant relationship between menstrual cycle phase and proportion of participants 
who experienced persecution was found (χ² (1, N=278)= 3.64, p<0.001), in that a 
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higher proportion of participants experienced some persecution at the paramenstrual 
phase (80.2%) than at mid-cycle (73.4%).  However the effect size was small (V= 0.11).  
The mid-cycle phase is much similar to the proportion of participants that Melo et al. 
(2008) found reported some level of persecution (approximately 72%).  Figure 2 
illustrates the comparisons between phases. 
 
Figure 2 Percentage of sample experiencing persecution at each phase 
 
3.2.5 Proportion of participants experiencing deservedness.  Items on the PADS 
are only completed if the participant reports a certain level of persecution.  This mean 
that as participants reported different amounts of persecution at different time points, 
there were different participants reporting deservedness scores at each phase.  Due to 
this reason, and the non-parametric nature of the data a Chi-square test was conducted 
to examine whether there was a difference between the phases in terms of the proportion 
of people that felt that their experience of persecution was deserved and those who did 
not.   
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The developers of the PADS do not provide a clear procedure for group allocation.  
However, they do suggest that for some purposes a conservative approach to exploring 
deservedness is to include only participants who complete at least three deservedness 
items.   Pickering et al. (2008) used the median score to divide the subgroup of their 
participants into groups based on deservedness scores.  The median score on the 
deservedness score from data collected in week1 was 1.29.   
 
Therefore, for this part of the analysis, participants who answered at least three 
deservedness items were selected and those scoring less than 1.29 were allocated to the 
“poor-me” group.  Those scoring more than 1.29 were allocated to the “bad-me” group.   
A significant relationship between menstrual cycle phase and proportion of participants 
allocated to each group was found (χ²(1, N=297)= 5.325, p=0.01).  A higher proportion 
of participants were allocated to the “bad-me” group at the paramenstrual phase (42.4%) 
than at mid-cycle (29.5%).  However the effect size was small (V= 0.13).  Figure 3 
illustrates these comparisons. 
 
Figure 3 Percentage of sample allocated to poor-me or bad-me groups at each phase. 
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3.2.6  Summary 
 
A significant impact of menstrual cycle was found.  Participants had lower positive self-
esteem scores at the paramenstrual phase, and higher levels of negative self-esteem, 
anxiety, depression and persecution.  A significantly higher proportion of participants 
had persecutory experiences at the paramenstrual phase.  At the paramenstrual phase, a 
higher proportion of participants believed that their expereinces of persecution were 
deserved.  
 
3.3 Investigation of deservedness groups 
3.3.1 Differences between deservedness groups 
Kruskal-Wallis tests were conducted at each time point to investigate whether there 
were differences between the three groups.  At the paramenstrual phase, significant 
differences were found in anxiety (H(2)= 17.38, p<0.001), depression (H(2) = 9.54, 
p=0.01),  positive self-esteem (H(2) = 16.28, p <0.001), negative self-esteem (H(2) = 
23.75, p <0.001) and persecution (H(2)= 7.45, P=0.02). 
 
At the mid-cycle phase significant differences were also found between anxiety (H(2)= 
49.64, p<0.001), depression (H(2) = 35.00, p<0.001),  positive self-esteem (H(2) = 
72.73, p <0.001), negative self-esteem (H(2) = 67.53, p <0.001) and persecution (H(2) 
157.73, <=0.001). 
 
Post-hoc tests were conducted to evaluate pair-wise differences among these groups.  
To protect against Type 1 errors, the Bonferroni approach was used (p=0.017).  The 
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results of these tests indicated a significant difference between all groups (p<0.001), see 
Table 7 for group median scores, effect sizes are reported in Table 8.   
 
3.3.2 Summary.  This tells us that women who experienced no persecution were 
the least distressed.  The bad-me group were the most distressed, experiencing higher 
levels of depression, anxiety, persecution and negative self-esteem. 
 
However, the PADS was not designed to allocate poor-me and bad-me groups and 
therefore does not have a clear cut-off point for allocation. Therefore in testing 
hypotheses three and four, it was also important to investigate the relationships of 
persecution and deservedness with other variables.  
 
Table 7  
Deservedness Subgroup Median Scores 
  Paramenstrual Mid-cycle 
 No 
Paranoia  
Poor 
Me 
Bad-
Me 
 No 
Paranoia 
Poor-
me 
Bad-
me 
n 120 91 67  139 98 41 
Anxiety 5.00 8.00 11.00  4.00 7.00 9.00 
Depression 2.00 4.00 6.00  1.00 2.00 5.00 
Positive Self-
esteem 
55.00 47.00 38.00  57.00 49.00 38.00 
Negative Self-
esteem 
25.50 31.00 40.00  25.00 31.00 40.00 
Persecution 0.40 1.70 2.10  0.30 1.70 2.10 
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Table 8 
 Effect Sizes of Post Hoc Comparisons between Deservedness Groups 
 Paramenstrual  Mid-cycle 
 No 
Paranoia/ 
Poor-Me 
Poor-Me/ 
Bad-Me 
No 
Paranoia/ 
Bad Me 
 No 
Paranoia/ 
Poor-Me 
Poor-Me/ 
Bad-Me 
No 
Paranoia/ 
Bad Me 
 Anxiety 0.37**** 0.23 * 0.52***  0.35**** 0.17 * 0.44**** 
Depression 0.21 **** 0.26**** 0.45****  0.18 *** 0.26**** 0.43**** 
Positive  
self-esteem 
0.28 **** 0.42**** 0.61****  0.37**** 0.42**** 0.55**** 
Negative 
Self-esteem 
0.37**** 0.42**** 0.64****  0.36**** 0.42**** 0.52**** 
Persecution 0.84**** 0.24*** 0.82**  0.71**** 0.24, *** 0.67**** 
Note 1 * p=0.02. ** p=0.01. *** p=0.002, ****p<0.001 
 
3.4 Correlations between variables 
 
The remaining analysis was conducted using only data from participants who completed 
at least one deservedness item.  This decision was made because hypotheses 3 to 5 are 
primarily interested in the relationship that persecution and deservedness have with the 
other variables.  Therefore it is acceptable to only conduct the analysis on people 
reporting at least a low level of persecution.  However, Melo et al. (2008) state that 
including participants who complete at least one deservedness item yields a more 
inclusive sample than the more conservative approach, while also, from their analysis, 
still producing very similar response patterns.  Therefore, including participants who 
completed at least one deservedness item seemed to balance inclusivity with selection of 
the population of interest.  
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3.4.1 Spearman’s correlations. In relation to hypothesis three and four, a 
Spearman‟s correlation coefficient was conducted to investigate the relationships 
between persecution, deservedness, self-esteem, anxiety and depression.  Table 9 
displays the results of these correlations; Appendix J displays full correlation 
information between all variables.  
 
At both time points, persecution and deservedness were significantly correlated with the 
other variables.  Positive self-esteem had a significant negative correlation with 
persecution and deservedness. Negative self-esteem, anxiety and depression were 
positively correlated with both persecution and deservedness.  Although the correlations 
support the hypothesis that increased deservedness will be related to increased 
depression scores, it is of interest that the relationship between depression and 
persecution was stronger.   It is also interesting that the relationship between 
deservedness and depression is stronger at the paramenstrual phase compared to mid-
cycle. 
Table 9 
Spearman‟s Correlation Coefficients between Measures at the Paramenstrual and Mid-
cycle Phases 
 Phase Anxiety Depression Positive 
Self-
esteem 
Negative 
Self-
esteem 
Persecution Paramenstrual 
phase ᵅ 
0.48**** 0.33**** -0.52**** 0.56**** 
Mid-cycleᵅ 0.44**** 0.37**** -0.49**** 0.49**** 
Deservedness Paramenstrual 
phaseᵇ 
0.30**** 0.31**** -0.52**** 0.50**** 
Mid-cycleᶜ 0.25**** 0.21*** -0.46**** 0.48**** 
Note ᵅ N=278, ᵇn=223, ᶜn=204; ***p=0.002 (two-tailed) **** p<0.001 (two-tailed) 
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3.4.2 Summary.  This confirms that increased persecution would be related to 
increased levels of anxiety.  It also confirms that deservedness is related to increased 
levels of depression.  However, the strength of this relationship is not as strong as the 
relationship between persecution and depression.  Both persecution and deservedness 
have strong relationships with self-esteem. 
 
3.5 Deservedness, persecution and self-esteem. 
In relation to hypothesis 4 a moderation regression analysis was conducted following 
the method used by Sheeran, Trafimow and Armitage (2003).  This analysis 
investigated whether deservedness would affect the relationship between self-esteem 
and persecution.   Self-esteem was entered as the dependent variable because the focus 
of the hypothesis was on indentifying whether the impact that persecutory feelings have 
on self-esteem is different when the persecution is felt to be deserved than when it is 
not.  To reduce potential multi-collinearity, the variables were mean-centred (Aiken & 
West, 1991).   
 
3.5.1 Positive self-esteem.  A three step hierarchical regression was conducted 
where positive self-esteem was the dependent variable.  Persecution was entered into 
the equation at the first step, deservedness was entered at the second step, and the 
interaction of persecution by deservedness was entered as the final step.  Persecution 
accounted for a significant proportion of variance in positive self-esteem, R² = 0.31, 
F(1,221) = 97.06, P<0.001.  This means that persecution accounted for 31% of the 
variance of positive self-esteem. The second step accounted for a significant increase (F 
(2, 220) = 77.47, p<0.001) in the overall variance of the model (R² change = 0.11).  This 
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demonstrates that 11% of the variance can be accounted for by deservedness.  The third 
step did not produce a significant change in R² (p=0.58), indicating that the interaction 
between deservedness and persecution did not significantly moderate the relationship 
between persecution and positive-self-esteem.  The results of this regression are 
displayed in Table 10.   
 
Table 10 
Summary of the Moderation Regression Analysis of Deservedness on the Relationship 
between Persecution and Positive Self-Esteem at the Paramenstrual Phase 
 Variable B SE B β P 
Step1  Persecution -7.06 0.72 -0.55 <0.001 
Step 2 Persecution 
Deservedness 
-5.35 
-4.26 
0.71 
0.67 
-0.41 
-0.36 
<0.001 
<0.001 
Step 3 Persecution 
Deservedness  
Interaction        
-5.30 
-4.24 
-0.34 
0.72 
0.67 
0.61 
-0.41 
-0.35 
-0.03 
<0.001 
<0.001 
0.58 
 
This process was repeated for positive self-esteem at mid-cycle, resulting in the same 
pattern.  Persecution accounted for a significant proportion of variance in positive self-
esteem, R² = 0.27, F(1,202) = 75.43, P<0.001.  This means at mid-cycle persecution 
accounted for 27% of the variance of positive self-esteem. The second step accounted 
for a significant increase (F (2, 201) = 60.63, p<0.001) in the overall variance of the 
model (R² change = 0.10).  This demonstrates that 10% of the variance at mid-cycle can 
be accounted for by deservedness.  The third step did not produce a significant change 
in R² (p=0.62).  The results are summarised in Table 11.  
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Table 11  
Summary of the Moderation Regression Analysis of Deservedness on the Relationship 
Between Persecution and Positive Self-Esteem at Mid-Cycle 
 Variable B SE B β P 
Step1  Persecution -6.86 0.79 -0.52 <0.001 
Step 2 Persecution 
Deservedness 
-5.33 
-4.44 
0.78 
0.77 
-0.41 
-0.34 
<0.001 
<0.001 
Step 3 Persecution 
Deservedness 
 Interaction        
-5.27 
-4.40 
-0.35 
0.79 
0.77 
0.70 
-0.40 
-0.34 
-0.03 
<0.001 
<0.001 
0.62 
 
3.5.2 Negative self-esteem.  The procedure was then repeated with negative self-
esteem as the dependent variable.  At the paramenstrual phase, persecution explained a 
significant proportion of variance in negative self-esteem, R² = 0.35, F(1,221) = 120.60, 
P<0.001.  This means that persecution accounts for 35% of the variance of negative 
self-esteem. The second step accounted for a significant increase (F (2, 220) = 88.98, 
p<0.001) in the overall variance of the model (R² change = 0.09).  This demonstrates 
that 9% of the variance can be accounted for by deservedness. The entry of the 
interaction between persecution and deservedness at the third step contributed a 
significant (F (2, 200) = 61.61, p<0.001), but small increase in the variance accounted 
for (R² change = 0.01, p-0.04).  See Table 12 for a summary. 
 
At mid-cycle, persecution explained a significant proportion of variance in negative 
self-esteem, R² = 0.27, F(1,202) = 77.23, P<0.001.  This means that persecution 
accounts for 27% of the variance of negative self-esteem. The second step accounted for 
a significant increase (F (2, 201) = 65.33, p<0.001) in the overall variance of the model 
(R² change = 0.12).  This demonstrates that, at mid-cycle, 12% of the variance can be 
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accounted for by deservedness. The entry of the interaction between persecution and 
deservedness at the third step contributed a significant, (F (2, 200) = 46.37, p<0.001) 
but small increase in the variance accounted for (R² change = 0.02, p=0.02).  See Table 
13 for a summary. 
 
Table 12 
Summary of the Moderation Regression Analysis of Deservedness on the Relationship 
Between Persecution and Negative Self-Esteem at the Paramenstrual Phase 
 Variable B SE B β P 
Step1  Persecution 6.84 0.62 0.59 <0.001 
Step 2 Persecution 
Deservedness 
5.40 
3.58 
0.62 
0.59 
0.47 
0.33 
<0.001 
<0.001 
Step 3 Persecution 
Deservedness  
Interaction        
5.23 
3.49 
1.09 
0.62 
0.58 
0.53 
0.45 
0.32 
0.10 
<0.001 
<0.001 
<0.001 
 
Table 13 
Summary of the Moderation Regression Analysis of Deservedness on the Relationship 
Between Persecution and Negative Self-Esteem at Mid-Cycle 
 Variable B SE B β P 
Step1  Persecution 5.80 0.66 0.53 <0.001 
Step 2 Persecution 
Deservedness 
4.44 
3.94 
0.64 
0.63 
0.40 
0.36 
<0.001 
<0.001 
Step 3 Persecution 
Deservedness  
Interaction        
4.21 
3.81 
1.34 
0.64 
0.63 
0.57 
0.38 
0.35 
0.13 
<0.001 
<0.001 
<0.001 
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Following the procedure described by Aitken and West (1991, pp 9-20) an analysis of 
simple slopes was conducted at three levels of the moderator, deservedness; low (one 
standard deviation below the mean), moderate (the mean) and high (one standard 
deviation above the mean).  These slopes are illustrated in Figure 4 for paramenstrual 
phase and Figure 5 for mid-cycle.  At the paramenstrual phase slopes with high and low 
values of deservedness were significantly different from zero, (the standard error and t-
test are identical at each value: t (219)=2.06,  p=0.04).  The slopes were also 
significantly different from zero at mid-cycle , t (200)=2.35,  p=0.02).   
  
This analysis illustrates that as level of deservedness increases the relationship between 
persecution and negative self-esteem intensifies.  The illustration produced by an 
analysis of simple slopes provides an indication of the impact that the moderating 
variable has, in that, the more that the lines deviate from parallel, the greater the effect 
that the moderator variable has.  As can be seen, the impact of deservedness upon the 
relationship between persecution and negative self-esteem is moderate. 
 
3.5.3 Summary.  These results show that the positive relationship between 
negative self-esteem and persecution is moderated by deservedness, such that as 
deservedness increases the relationship between persecution and negative self-esteem 
becomes stronger.  These interactions were the same at both phases of the menstrual 
cycle.  The same moderation effect was not present for positive self-esteem. 
 
86 
 
 
Figure 4  Paramenstrual phase: Moderating effect of deservedness on the relationship 
between persecution and negative self-esteem 
 
 
Figure 5 Mid-cycle phase: Moderating effect of deservedness on the relationship 
between persecution and negative self-esteem 
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3.6 Changes in self-esteem, persecution and deservedness 
To further investigate the relationships between persecution, deservedness and self-
esteem, the relationships between how much these variables changed between the 
paramenstrual and mid-cycle phases was explored.   For each variable, the participants‟ 
score at mid-cycle was subtracted from the score at the paramenstrual phase, producing 
a “change score”.   
 
3.6.1 Correlations of change in variables. A Spearman‟s Correlation Coefficient 
was conducted to examine the relationship between the change in positive and negative 
self-esteem and the other variables.   As can be seen in Table 14 changes in positive 
self-esteem had a significant negative correlation with change in each of the other 
variables.  Changes in negative self-esteem had a significant positive relationship with 
anxiety, depression, persecution and deservedness, and a negative relationship with 
changes in positive self-esteem. 
 
Table 14  
 Inter-correlations between Change in Positive and Negative Self-Esteem and Change 
on the Other Measures (N=237) 
 Negative 
Self-esteem 
Anxiety Depression Persecution Deservedness 
Positive Self-
esteem 
-0.59**** -0.52**** -0.61**** -0.54**** -0.43**** 
Negative Self-
esteem 
 0.52**** 0.53**** 0.55**** 0.45**** 
Note **** p<0.001 
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3.6.2 Changes in positive self-esteem.  A hierarchical regression was conducted 
to examine the unique contributions of persecution and deservedness when the other 
variables had been controlled.  For the change in positive self-esteem a significant 
change in adjusted R² value was found at steps 2 and 3, where step 1 included (changes 
scores for) negative self-esteem, anxiety and depression (F (3, 233) = 70.80, p<0.001, 
R²=0.48, p<0.001) and where step 2 included the change in persecution (F (4, 232) = 
59.25, p<0.001, R² change =0.03, p<0.001), and step 3 included the change in 
deservedness (F (5,231) = 48.88, p<0.001, R²change =0.01, p=0.04).  Although the 
unique contribution of deservedness was significant, the effect size was very small.  As 
can be seen in Table 15 at step one, anxiety was almost not significant (p=0.05).When 
persecution was entered into the model, anxiety became non-significant. 
Table 15 
 Summary of Hierarchical Regression Analysis for Variables Predicting Change in 
Positive Self-Esteem (N= 237) 
 Variable 
(Change in) 
B SE B β P 
Step 1 Negative SE 
Anxiety 
Depression 
-0.38 
-0.25 
-0.71 
0.06 
0.13 
0.13 
-0.34 
-0.13 
-0.34 
<0.001 
0.05 
<0.001 
Step 2 Negative SE 
Anxiety 
Depression 
Persecution 
-0.30 
-0.14 
-0.66 
-2.66 
0.07 
0.13 
0.13 
0.73 
-0.27 
-0.07 
-0.32 
-0.21 
<0.001 
0.28 
<0.001 
<0.001 
Step 3 Negative SE 
Anxiety 
Depression 
Persecution 
Deservedness 
-0.27 
-0.11 
-0.67 
-2.22 
-1.05 
0.07 
0.13 
0.13 
0.75 
0.51 
-0.24 
-0.06 
-0.32 
-0.18 
-0.11 
<0.001 
0.40 
<0.001 
0.004 
0.04 
Note R²=0.48 for step 1; ΔR²= 0.50 for step 2; ΔR²=0.50 for step 3 
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3.6.2 Hierarchical regression of changes in negative self-esteem. For change in 
negative self-esteem scores a significant change in adjusted R² value was found at steps 
1 and 2, where step 1 included (changes scores for) positive self-esteem, anxiety and 
depression (F (3, 233) = 56.76, p<0.001) and where step 2 included the change in 
persecution (F (4, 232) = 49.37, p<0.001, R² change =0.04), and step 3 included the 
change in deservedness (F (5,231) = 41.34, p<0.001, R²change =0.01, p=0.02).  The 
unique contribution of deservedness was significant, however the effect size was very 
small.  Table 16 summarises the regression model. 
 
Table 16 
 Summary of Hierarchical Regression Analysis for Variables Predicting Change in 
Negative Self-Esteem (N= 237) 
 Variable 
(Change in) 
B SE B β P 
Step 1 Positive SE 
Anxiety 
Depression 
-0.35 
0.40 
0.29 
0.06 
0.12 
0.13 
-0.38 
0.22 
0.16 
<0.001 
0.001 
0.03 
Step 2 Positive SE 
Anxiety 
Depression 
Persecution 
-0.27 
0.27 
0.27 
2.77 
0.06 
0.12 
0.13 
0.69 
-0.29 
0.15 
0.14 
0.24 
<0.001 
0.03 
0.04 
<0.001 
Step 3 Positive SE 
Anxiety 
Depression 
Persecution 
Deservedness 
-0.24 
0.24 
0.28 
2.28 
1.13 
0.06 
0.12 
0.13 
0.71 
0.48 
-0.27 
0.13 
0.15 
0.20 
0.13 
<0.001 
0.05 
0.03 
0.002 
0.02 
Note R²=0.42 for step 1; ΔR²= 0.45 for step 2; ΔR²=0.46 for step 3 
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3.7 Overall summary of results 
 
The results indicate that:- 
 Levels of anxiety, depression, persecution and negative self-esteem are higher at 
the paramenstrual phase than at mid-cycle. 
 Levels of positive self-esteem are lower at the paramenstrual phase. 
 A greater proportion of the sample experienced feelings of persecution at the 
paramenstrual phase. 
 Of these, a greater proportion felt that persecution was deserved at the 
paramenstrual phase (this effect size was small). 
 Increased persecution was related to increased anxiety, depression, and negative 
self-esteem, and lower positive self-esteem. 
 As feelings of deservedness increase the relationship between persecution and 
negative self-esteem is intensified. 
 Although the individual variables fluctuated, the relationships between the 
variables remained fairly stable. 
 Changes in levels of persecution and deservedness contribute significantly to 
predictions of changes in self-esteem, even when changes in anxiety and 
depression are controlled. 
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4. Discussion 
 
4.1 Effect of cycle phase 
As found by previous research, the sample had higher levels of anxiety and depression  
at the paramenstrual phase than at mid-cycle (Farage et al., 2008).   Hill and Durante 
(2009) reported lowered levels of self-esteem at ovulation.  However, the present study 
found that positive self-esteem was lower, and negative self-esteem was higher, at the 
paramenstrual phase than at mid-cycle.  This finding is consistent with the increase in 
depression and anxiety levels and the evidence from the PMS literature which reported 
lower levels of self-esteem premenstrually (Taylor, 1999; Bloch et al., 1997).   
 
Levels of persecution have not been well researched in relation to the menstrual cycle, 
and the current study is the first to focus specifically on persecution and menstrual cycle 
phase.  The results found that at the paramenstrual phase levels of persecution were 
higher than at mid-cycle.  Further, a greater proportion of the sample experienced 
persecution in the paramenstrual phase.  Of the women who experienced persecution, a 
higher percentage felt that the persecution was deserved at the paramenstrual phase than 
at mid-cycle.   Applying Cohen‟s (1988; 1992) conventions for effect sizes, cycle phase 
had a medium effect for both anxiety and depression, indicating that even within a non-
clinical population the menstrual cycle has a significant impact on distress.  Although 
the effect sizes for both persecution and deservedness were smaller, they were both 
related to anxiety and depression.  Therefore it is likely that both of these factors can be 
an important component of the distress experienced.   These findings are especially 
important given the body of literature which indicates increased interpersonal sensitivity 
at the paramenstrual phase (Pinkerton et al. 2010).  It would suggest that for some 
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women interpersonal interactions may be interpreted differently at this phase.  
Specifically, the increased persecution may mean they are more sensitive to perceived 
attacks or criticisms from others, which in turn may impact on how they respond to 
people around them, impacting on both personal and professional relationships.   
 
The increased deservedness suggests that women may also then feel that these perceived 
attacks have in fact occurred because of something bad about them, impacting on how 
they feel about themselves.  In western, and many other cultures, menstruation is often 
related to feelings of being dirty and shameful, and many women go to considerable 
lengths to conceal the fact that they are menstruating (Lee, 1994; Johnston-Robledo, 
Barnack, Wares, 2006).  It is possible that this sense of shame may be why there is a 
greater sense that persecution is deserved during the paramenstrual phase. 
 
4.2 Persecution, deservedness and self-esteem 
 
At both phases, increased deservedness was associated with increased depression.   This 
finding was in agreement with previous research about the concept of deservedness (e.g. 
Chadwick et al., 2005).  Both positive and negative self-esteem were related to levels of 
persecution and deservedness.  This relationship was very similar at both phases.  The 
examination of change scores provides support for the relationship between persecution, 
deservedness and self-esteem.  It also shows that the amount of change in persecution 
and deservedness scores makes a unique contribution to predictions of how much self-
esteem scores will change over the cycle.  The contribution of change in deservedness 
to these models was quite small, which is likely to be due to the correlations with all of 
the other variables.  It is of note, that the contribution was particularly small for change 
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in positive self-esteem.  Together these two findings indicate that, although levels of 
each variable may change, the relationships between the variables remained roughly the 
same, demonstrating stability in these relationships, regardless of an external factor, 
cycle phase. 
 
Bentall et al. (2002) propose that the “poor me” stance, that persecution is not deserved, 
is part of a system of defences intended to prevent experiences of the self as bad or 
flawed, thus protecting self-esteem.  The results found in the present study 
demonstrated that deservedness had a different relationship with positive than negative 
self-esteem.  A fairly strong negative relationship was found where increased 
persecution was related to decreased positive self-esteem.  When the sample was 
divided into the groups “no-persecution”, “poor-me” and “bad-me”, the bad-me group 
had the lowest positive self-esteem, followed by poor-me, then no-persecution.  
However, the bad-me group also had the highest level of persecution, which may have 
accounted for the lower positive self-esteem score.  The moderation regression supports 
this view, as deservedness did not significantly change the relationship between 
persecution and positive self-esteem.  These results suggest that the presence of 
persecution has an impact on positive self-esteem, but deservedness does not 
significantly affect this relationship.   
 
The investigation of negative self-esteem demonstrated a different pattern.  Persecution 
was also related to negative self-esteem, in that as persecution increased, so did negative 
self-esteem.  However, deservedness moderated this relationship, in that increased 
deservedness intensified the relationship between persecution and negative self-esteem.  
This would suggest that while levels of persecution are related to both positive and 
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negative self-esteem, the impact of deservedness was only an important factor for 
negative self-esteem.    
 
This finding illustrates that measuring both positive and negative self-esteem may be 
important when exploring the relationships between persecution, deservedness and self-
esteem.   It is possible that some of the inconsistencies in previous research into 
persecution and self-esteem may have arisen as a result of the measures used. 
 
These findings offer support for the theory that people who feel they deserve to be 
persecuted have lower negative self-esteem. However, a complication of interpreting the 
current finding is that people allocated to the “no-persecution” had less negative self-
esteem than both paranoia groups.  Therefore it is not clear whether persecution without 
deservedness is protecting self-esteem, or whether feeling that persecution is deserved 
causes (or is caused by) more negative self-esteem.  This lack of clarity may well be a 
product of investigating a non-clinical population. Self-esteem “protection” may only be 
observable when comparing a clinical “poor-me” paranoid group to a non-clinical 
control group.  
 
4.3 Clinical Implications 
 
Many service user groups have expressed a desire for less reliance on pharmaceutical 
approaches (Sainsbury Centre for Mental Health, 2006). However, for women who are 
affected by their menstrual cycle, at present such fluctuations in mental health are 
predominantly managed through medical therapies (Brockington, 2005; Bergemann et 
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al., 2007).    Therefore the clinical implications of this study arise from the drawing 
together of knowledge from the psychosis literature and from PMS literature.   
 
For example, Blake (1995) proposes a cognitive model for PMS.  She suggests that 
some women may hold preconceptions that the paramenstrual phase is a time of 
increased difficulty in functioning.  If one of these women is experiencing other 
psychosocial stressors then noticing a physiological change that she associates with 
menstruation may trigger these negative schemas.  Accordingly, these physiological 
changes are interpreted as threatening because she sees them as indicators that 
functioning will become more difficult at a time when she may already be struggling.  
As a result she begins to feel anxious and depressed.   It is likely that in women 
vulnerable to feelings of persecution, this would also represent a period when they 
might feel attacked, criticised or persecuted by others.  Blake suggests that two different 
responses occur, which are part of vicious circles of negative thinking.  The first is that, 
feeling anxious and depressed, a woman may be more sensitive, leading to resentment 
and anger in response to demands or criticisms from others.  This leads in turn to 
irritable outbursts and reinforces the belief that the paramenstrual phase is a period of 
interpersonal difficulty. Using the types of paranoia proposed by Trower and Chadwick 
(1995), it is possible that this response pattern would fit with a poor-me presentation, 
where negative events are attributed to the other who is perceived as bad and 
persecuting the self unjustly.  The other cycle Blake describes is characterised by the 
woman feeling less able to cope at this time, but that she feels guilty and self-critical 
about this, leading to further low mood.  This response would seem to fit with the bad-
me presentation, where the feeling of persecution is felt to be deserved because the self 
is in fact “bad” or lacking.   
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The cognitive therapy for PMS developed by Blake focuses on giving a woman the 
ability to cope with the paramenstrual phase, to be able to understand her perceptions 
and reduce her feelings of distress.  Paranoid thinking styles represent particular 
perceptions of interactions.  It would therefore seem important to incorporate attention 
to paranoid thinking styles within models such as Blake‟s.  For example, if feelings of 
persecution are accompanied by feelings that persecution is deserved because of a 
woman‟s own attitudes towards menstruation, then these attitudes can be modified to 
reduce the distress associated with menses.  Furthermore, by understanding and being 
able to recognise whether and when she is feeling paranoid, she can engage in 
techniques such as thought testing and challenging or behavioural experiments (Smith, 
Nathan, Juniper, Kingsep, & Lim, 2003).  If the psychological mechanism is that 
menstruating acts as a stressor, then it is possible that paranoid thinking styles may arise 
at other times and in response to different stressors.  If this is the case, then she could 
also generalise coping skills to other stressful situations. 
 
For women prone to paranoid thinking or psychotic illnesses, awareness of the potential 
impact of the menstrual cycle may also be useful.  The stress-vulnerability model 
(Zubin and Sping, 1977) is prominent within strategies for management and relapse 
prevention of psychotic experiences. The paramenstrual phase could be conceptualised 
as a period of increased stress or vulnerability to experiences of persecution for some 
women.  Exploration by clinicians can help women be aware of and prepared for this 
potential stressor.  Further, being able to understand causes of persecutory or psychotic 
symptoms can reduce the distress these experiences cause (Smith et al., 2003).  
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Therefore being able to attribute an increase in feelings of persecution to menstrual 
cycle phase may reduce the distress that paranoid thoughts and feelings cause. 
 
In addition, one of the aims of investigating these two types of paranoia has been to 
explore the need for different therapeutic approaches (Chadwick, Trower, Juusti-Butler 
& McGuire, 2005).  It may be that different therapeutic skills are required at different 
menstrual phases, and clinicians would need to be able to respond to idiosyncratic 
changes in individual women.    
 
 4.4 Limitations 
 
The study had a number of limitations which need to be considered when interpreting 
the results.  One consideration is that of timing.  Hill and Durante (2009) identified 
lowered self-esteem at ovulation using specific hormonal measures.  As the current 
study used an online study design, participants‟ cycle phase was estimated and could 
not be verified.  This would mean that some women may have been ovulating and some 
may not, which may have affected the results. It is also possible that different results 
may have been obtained if one of the comparison points had been strictly the 
premenstrual phase, as symptoms may be relieved once menstruation begins (Blake, 
1995).  However, this would pose a design problem as measures would have to either be 
administered daily or rely on participant estimations of when menstruation was 
expected which could be affected by inaccurate estimations (Jukic, Weinberg, Wilcox, 
McConnaughey, Hornsby & Baird, 2007).  It would also have been beneficial to have a 
third comparison point in the follicular phase.  Unfortunately to do so here would have 
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involved excluding a number of participants, so it was decided to maximise the number 
of responses that could be used, and examine just two comparison points. 
 
A further limitation is that the study was only conducted over one menstrual cycle.  It is 
generally accepted that menstrual cycle research should be conducted over a period of 
two cycles, to account for idiosyncrasies (Haywood, Slade and King, 2007).  The 
decision to measure one cycle was based on the anticipation that it would be difficult to 
retain a high number of participants for such an extended period (an anticipation that 
was corroborated by the high drop-out rate), and that women who did commit to such a 
long period were likely to be particularly interested in menstrual cycle research, and 
thus skew the sample. 
  
It is also likely that as participants were aware of the study purpose, the results may 
have been influenced by participants‟ expectations of mood changes, and it is possible 
that only women who were interested in mood changes or menstruation were recruited 
(Slade, 1984).   Generalisability is limited by studying a primarily UK population and 
because over half of the sample was recruited through educational establishments.  
Further, using an online study may have limited the sample as the Office for National 
Statistics (2010) stated that in 2010, 97% of adults educated to a degree level regularly 
accessed the internet, while only 45% of people without formal qualifications did so.  
However, as 76% of women, and 81-82% of people aged between 18 and 45, used the 
internet every day, the bias may be reduced in the population of interest here.  It is 
hoped that the large sample size will counteract some of the issues regarding responder 
bias, while also improving the generalisability of the study.    
 
99 
 
4.5 Future Research 
Since paranoia has generally not been researched in relation to the menstrual cycle, the 
findings reported here would need to be replicated by future studies.  This is especially 
true as the issue of generalisability is important.  Because the results indicate a 
significant effect of menstrual cycle phase on persecution within a non-clinical sample, 
there is an indication that this effect is important for women other than those diagnosed 
with PMS or other mental health problems.   If this can be generalised then the findings 
could be usefully employed to educate society about the impact of the menstrual cycle.  
It will be also important to investigate the impact of the menstrual cycle within clinical 
populations and to clarify the extent of this effect.   
 
The present study did not concentrate on the causes of the observed fluctuations.  
Previous researchers have focussed on the interaction between physiological factors 
such as oestrogen levels and psychotic illnesses such as schizophrenia.  However, this 
study found that use of hormonal contraception was not associated with differences in 
variable scores across the cycle, which may support the view that social and 
psychological factors are important as well, and paranoid experiences and related 
difficulties arise as a result of an interaction between biological, social and 
psychological factors.   
 
There are indeed numerous complex factors implicated in theories of paranoia, self-
esteem and menstruation-related distress which have not been considered here.  For 
example, concrete thinking, jumping to conclusions, attribution styles and sleeping 
difficulties have all been related to paranoia.  The paramenstrual phase has been linked 
to numerous physiological and cognitive changes (Farage et al., 2008).  As an example, 
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difficulty in sleeping has been noted during the cycle (Manber & Bootzin, 1997) and 
could be one mechanism that contributes to increased vulnerability to paranoia.   
 
The results showed that levels of persecution increased and a greater proportion of the 
sample experienced paranoia at the paramenstrual phase than at mid-cycle.  However, 
questions remain as to precisely what mechanism caused the increase in persecution.  
Was the presentation of these thinking styles caused by increased stress due to social or 
psychological processes as, for example, suggested by Blake (1995)?  Or, did they arise 
because of an increase in vulnerability caused by lowered oestrogen levels as suggested 
by Riecher-Rossler (2002)?  Or was there an interaction between these and other 
factors?  Further research is needed to unpick these various strands and explain why 
paranoia and self-esteem might be affected by menstrual cycle phase. 
 
The results here also suggest that women are more likely to experience “bad-me” 
paranoia at the paramenstrual phase.  However, this was not the main focus of the study.  
More finely tuned research is required to explore in detail whether women fluctuate in 
terms of the deservedness they experience, or whether women who are not usually 
paranoid tend to present as predominantly “bad-me” at the paramenstrual phase, 
possibly because of the feelings of shame discussed above.  
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5.  Conclusion 
 
This study adds to the body of literature linking mental health to the menstrual cycle.  
The results from this study indicate that the paramenstrual phase is a time when some 
women are vulnerable to feelings of anxiety, depression, and persecution, low positive 
and high negative self-esteem.  More of the women who experienced persecution felt 
that it was deserved at the paramenstrual phase.   
 
At both phases, anxiety and depression were both related to persecution and 
deservedness.  There was a negative relationship between persecution and positive self-
esteem, and a positive relationship with negative self-esteem.  The results supported the 
theory that increased deservedness would be related to increased negative self-esteem, 
although a similar relationship was not found with positive self-esteem. The 
relationships between the variables remained fairly stable even though the levels of 
individual variables changed.  Changes in levels of persecution and deservedness 
significantly contributed to a model of change in negative self-esteem.  Although the 
contribution of deservedness was very small, especially for positive self-esteem.  
 
The interactions between self-esteem, persecution and the menstrual cycle were 
considered in the context of psychological models developed within the PMS and the 
psychosis literature.  The findings have implications for treatment approaches for 
women with menstruation-related difficulties and for women prone to paranoid 
thinking.  Furthermore, the study of self-esteem, persecution and deservedness 
contributes a new and important perspective to understanding the interpersonal 
difficulties that some women experience at the paramenstrual phase.  
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Appendix  A: Recruitment Information 
 
Women needed: Can you help with online research? 
 
 
Hello, 
 
I am a trainee Clinical Psychologist, studying at the University of Sheffield.  I am 
contacting you to tell you about my thesis research project and to invite you to 
participate.  My study is interested in the way that thoughts and beliefs change over the 
menstrual cycle. 
 
 Taking part involves completing a ten minute online questionnaire each week for four 
weeks (we would send you a friendly reminder email each week).   
 
For this study I need women aged 18-45 who menstruate regularly.  It does not matter 
at what point you are in your cycle when you enter. 
 
The study has received ethics approval from the University of Sheffield Department of 
Psychology Ethics Committee.  In accordance with ethical guidance, all information 
you provide will remain entirely confidential, and you are free to withdraw at any time.  
We will need your email address to send you weekly reminders, but this information 
will only be available to the researchers and will be destroyed as soon as the study is 
complete. 
 
If you are interested in taking part, please click here:  [enter link] 
 
If you have any further queries please do not hesitate to email me at 
pcp08rh@sheffield.ac.uk. 
 
If you know anyone else who might be interested in taking part, please do forward this 
email to them as we appreciate every participant. 
 
Thank you 
 
Rosalind Hall  
 
Researchers: 
 
Rosalind Hall     
Trainee Clinical Psychologist 
University of Sheffield 
 
 
Dr Georgina Rowse   Prof Pauline Slade 
Clinical Psychologist   Prof. Clinical Psychology 
University of Sheffield  University of Sheffield   
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Appendix B: Recruitment Email for The present Study and Study Conducted by Another 
Trainee 
 
Research: Participants needed! 
 
Hello, 
 
We are trainee Clinical Psychologists.  We are contacting you to tell you about two 
research projects and invite you to participate in either one or both of these studies.  
Both studies require filling an online questionnaire where you‟ll be asked some 
questions about your thoughts and feelings. 
 
Study 1: For women only and is looking at changes over the menstrual cycle.  We 
would therefore ask you to complete a ten minute online questionnaire each week for 
four weeks (we would send you a friendly reminder email each week).  For this study 
we need women aged 18-45 who menstruate regularly. 
 
Study 2: The other study is open to anyone, both men and women. For this study, you 
would need to complete a one-off questionnaire which takes 15 to 20 minutes. 
 
If you are a woman and would like to take part in both studies, you would complete the 
longer one-off questionnaire first,  and then on subsequent weeks you would only need 
to complete the shorter questionnaire. 
 
If you are interested in taking part in the studies click here: 
 
both studies:  https://www.surveymonkey.com/s/WR3JLYK 
 
Just study 1  https://www.surveymonkey.com/s/NJWWXFN 
 
Just study 2  https://www.surveymonkey.com/s/NCPSJPJ 
 
The study has received ethics approval from the Department of Psychology Ethics 
Sub-Committee. In accordance with ethical guidance, all information you provide will 
remain entirely confidential, and you are free to withdraw at any time. 
 
If you have any further queries please do not hesitate to email us at 
pcp08rh@sheffield.ac.uk (Rosalind Hall), or pcp08jmn@sheffield.ac.uk (Jenny 
Neubert). 
 
Many thanks 
 
Rosalind Hall and Jenny Neubert 
 
Researchers: 
 
Rosalind Hall  
Jenny Neubert     
Trainee Clinical Psychologists  
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Appendix C: Survey: Information for Participants, Consent, and Introductory Questions 
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   [Hospital Anxiety and Depression Scale] 
 
Not included due to copyright 
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The Self-Esteem Rating Scale 
 
Not included due to copyright. 
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Persecution and Deservedness Scale 
 
Not included due to copyright 
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Appendix  D: Weekly email 
Email Subject: Menstrual Cycle Research Project: Week 2/3/final week 
 
Dear participant, 
 
Thank you for agreeing to participate in my research project! 
 
It has now been a week since you completed your last questionnaire.  If you still want to 
take part in the study then please can you find some time over the next few days to click 
on the link below (or copy and paste it into your web browser) and complete your next 
questionnaire. 
 
All of your responses will remain completely confidential, and you are free to withdraw 
from the study at any time. 
 
[Enter link] 
 
Many thanks 
 
Rosalind Hall 
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Appendix  E: Reminder Email 
 
Dear Participant, 
 
You have recently entered my research study looking at thoughts, beliefs and the 
menstrual cycle.   I am contacting you today because I noticed that you haven‟t 
completed the next part of the study. 
If you do still want to participate, please use the link below to complete your next set of 
questions:- 
(Enter link) 
If you no longer want to take part, you can opt out of the study using the link below and 
we will not contact you again:- 
(opt out link) 
 
Thank you  
 
Rosalind Hall 
Trainee Clinical Psychologist 
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Appendix  F: Follow-up Email 
Subject: Menstrual Cycle Study: Follow-up 
Dear Participant, 
Thank you for your recent participation in my study looking at the way that thoughts, 
feelings and beliefs change over the menstrual cycle.  Your help is truly appreciated.   
I‟m emailing you again is to ask you for one final piece of information: the date that you 
started your next period after finishing the study, as this will allow me to make best use 
of the information you have already kindly given me.  
If you do know the date and are willing to provide this I would really appreciate it if 
you could email it to me at pcp08rh@sheffield.ac.uk  using the email account that I 
have contacted you on (you can just reply to this email directly). This information will 
be entirely confidential and used only for the purposes of the research described. 
 If you do not know, or do not want to provide this information then please just discard 
this email. 
Once more, thank you for all of the information you have provided. Please be assured I 
will not contact you again unless you have asked for a summary of our research 
findings. 
 Yours Sincerely 
Rosalind Hall 
Trainee Clinical Psychologist 
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Appendix G: Organisations Through Which Participants Were Recruited and Response 
Rate Estimates 
 
Table G1  
Organisations Contacted and Potential Advert Views 
 Visitors to site Advert hits 
www.aphrodite.com 13,000 members 400  
Barnsley College 360 female staff 
members 
 
www.creativewomensnetwork.co.uk Not available  
Daph-net   
www.essexmums.co.uk 6500  
Facebook  504 
www.getsetwomen.org 1,800  
www.leedsforum.co.uk  203  
Mumsnet. 25 million monthly 
hits 
Not available 
www.netmums.co.uk 10,100  
www.onlinepsychresearch.co.uk Not available  
Rotherhamweb.co.uk Not available  
Sheffield City Council Intranet  583  
Sheffield College Facebook Page Not available  
Sheffield feminist network  220 
www.sheffieldforum.co.uk 260,000 
visitors/month 
585  
Sofeminine.co.uk Not available  
www.thewi.org.uk 200,000 members 
majority over 45 
 
Ukfeminista.org.uk  156  
University of Sheffield volunteers list  3473 
University of Sheffield students 12877 12432 
University of Sheffield staff 3028  
www.wherewomenconnect.com 400  
Womensthoughts.co.uk 9000 monthly 
visitors (two months) 
 
http://www.workingwoman.org.uk 10,000  
Yorkshire Women‟s Entrepreneurs 3-400  
 
Table G 2  
Approximate response rates 
 Approximate Response rate 
University staff and students 4% 
Sheffield City Council 8% 
Colleges 11% 
“Mums” websites  1.3% 
Social networking sites 7% 
Women‟s networking organisations 5% 
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Appendix H: Kolmogorov-Smirnov and Trimmed Mean Analysis 
 
Table H1  
Summary of Kolmogorov-Smirnov Analyses indicating non-normal distribution of all 
measures 
Phase  N D  
Paramenstrual Anxiety 278 .11*  
 Depression 278 0.17*  
 Positive Self-
esteem 
278 0.08*  
 Negative Self-
esteem 
278 0.09*  
 Persecution  278 0.11*  
 Deservedness 224 0.15*  
Mid-cycle Anxiety 278 0.10*  
 Depression 278 0.21*  
 Positive Self-
esteem 
278 0.09*  
 Negative Self-
esteem 
278 0.10*  
 Persecution  278 0.11*  
 Deservedness 205 0.15*  
Note  *p<0.001 
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Table H2 
 Comparison of Means and 5% Trimmed Mean of All Measures 
 Paramenstrual Mid-cycle 
 Mean 5% Trimmed 
Mean 
 Mean 5% trimmed 
Mean 
Anxiety 7.78 7.61 6.1 5.96 
Depression 4.49 4.17 3.05 2.75 
Positive Self-
esteem 
47.54 47.86 49.67 50.20 
Negative Self-
esteem 
32.22 31.62 30.22 29.67 
Persecution 1.2986 1.2602 1.141 1.0863 
Deservedness 1.3614 1.3210 1.19 1.132 
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Appendix  I: Analysis of Sub-Groups 
Table I 1  
Results of Mann Whitney U Test of Differences Between Recruitment Groups 
Phase  University 
Mdn 
Community 
Mdn 
Z P  
(one-
tailed) 
Para-
menstrual 
Anxiety 7.00ᵅ 7.50ᶜ -0.40 0.34 
Depression 3.00ᵅ 4.00ᶜ -1.56 0.06 
 Positive Self-esteem 48.00ᵅ 47.50ᶜ -0.23 0.41 
 Negative Self-esteem 31.00ᵅ 31.00ᶜ -0.38 0.35 
 Persecution 1.10ᵅ 1.20ᶜ -0.15 0.44 
 Deservedness 0.88ᵇ 0.67   -0.99 0.17 
Mid-cycle Anxiety 6.00ᵅ 6.00ᶜ -0.62 0.26 
Depression 2.00ᵅ 2.00ᶜ -2.35 0.01* 
 Positive Self-esteem 51.00ᵅ 50.50ᶜ -0.53 0.31 
 Negative Self-esteem 28.00ᵅ 30.00ᶜ -1.18 0.12 
 Persecution 1.00ᵅ 1.00ᶜ -0.69 0.24 
 Deservedness 0.67ᵇ 0.76  -0.80 0.21 
Note  ᵅ n=152; ᵇ n=123;  ᶜ n=126;  n=101 *significant 
 
Table I 2   
Results of Mann Whitney U Test of Differences between Contraception Groups 
Phase  Using 
Hormonal  
Contraception 
Mdn 
Not Using 
Hormonal 
Contraception 
Mdn 
Z P 
(one-
tailed)  
Para-
menstrual 
Anxiety 7.00ᵅ 7.00ᶜ -0.08 0.46 
Depression 3.00ᵅ 4.00ᶜ -2.78 0.003* 
 Positive Self-
esteem 
50.00ᵅ 46.00ᶜ -1.74 0.04* 
 Negative Self-
esteem 
30.00ᵅ 32.00ᶜ -1.56 0.06 
 Persecution 1.20ᵅ 1.20ᶜ -0.33 0.37 
 Deservedness 0.77ᵇ 1.00  -0.79 0.21 
Mid-cycle Anxiety 6.00ᵅ 6.00ᶜ -0.86 0.19 
 Depression 1.00ᵅ 2.00ᶜ -1.8 0.04* 
 Positive Self-
esteem 
52.00ᵅ 50.00ᶜ -0.29 0.38 
 Negative Self-
esteem 
29.00ᵅ 29.00ᶜ -1.19 0.12 
 Persecution 1.00ᵅ 1.00ᶜ -0.16 0.44 
 Deservedness 0.75ᵇ 0.75  -0.29 0.39 
Note: ᵅ  n=89; ᵇ n=66; ᶜ n=189;   n=139 
*significant 
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Table I 3 
Summary of Wilcoxon signed ranks tests of changes in variables disaggregated by use 
of hormonal contraception 
  Paramenstrual 
Phase 
Mdn 
Mid-
cycle 
Mdn 
Z P Effect 
size r 
Power 
Not Using 
Hormonal 
Contraception 
Anxiety 7.00 6.00 -5.75 <0.001 0.42 0.99 
Depression† 4.00 2.00 -5.19 <0.001 0.38 0.98 
Positive 
Self-
esteem† 
46.00 50.00 3.86 <0.001 0.28 0.98 
Negative 
Self-esteem 
32.00 29.00 -
4.135 
=0.001 0.30 0.99 
Persecution 1.20 1.00 -3.55 <0.001 0.26 0.97 
Using 
hormonal 
contraception 
Anxiety 7.00 6.00 -3.26 -0.001 0.35 0.94 
Depression† 3.00 1.00 -2.52 =0.01 0.27 0.80 
Positive 
Self-
esteem† 
50.00 52.00 2.11 =0.04 0.22 0.64 
Negative 
Self-esteem 
30.00 29.00 -2.58 =0.01 0.27 0.80 
Persecution 1.20 1.00 2.25 -0.03 0.24 0.71 
Note † variables that were significantly different between groups. 
The Chi square could not be conducted (as in section 3.2.5) due to insufficient numbers 
in each group.  Further, deservedness scores were not significantly different between the 
groups so this analysis was unlikely to be necessary.  
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Appendix J: Correlation Matrixes  
Table J 1 
Paramenstrual Phase: Pearson Correlation Matrix 
 N Anxiety Depression Positive 
Self-
esteem 
Negative 
Self-esteem 
Persecution 
Anxiety 278 1.00* 0.59* -0.53* 0.58* 0.54* 
Depression 278 0.59* 1.00* -0.51* 0.50* 0.39* 
Positive Self-
esteem 
278 -0.53* -0.51* 1.00* -0.69* -0.53* 
Negative Self-
esteem 
278 0.58* 0.50* -0.69* 1.00* 0.61* 
Persecution 278 0.54* 0.39* -0.53* 0.61* 1.00* 
Deservedness 224 0.30* 0.31* -0.53* 0.50* 0.40* 
Note 2 * p<0.001 
 
Table J 2 
Mid-cycle Phase: Pearson Correlation Matrix 
 N Anxiety Depression Positive 
Self-
esteem 
Negative 
Self-esteem 
Persecution 
Anxiety 278 1.00* 0.58* -0.46* 0.52* 0.49* 
Depression 278 0.58* 1.00* -0.45* 0.45* 0.40* 
Positive Self-
esteem 
278 -0.46* -0.45* 1.00* -0.67* -0.53* 
Negative Self-
esteem 
278 0.52* 0.45* -0.67* 1.00* 0.59* 
Persecution 278 0.49* 0.40* -0.53* 0.59* 1.00* 
Deservedness 205 0.24* 0.21* -0.46* 0.48* 0.38* 
Note  * p<0.001 
